| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | benzodiazepine receptor binding | 2.64e-05 | 5 | 279 | 3 | GO:0030156 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine kinase adaptor activity | 9.78e-05 | 18 | 279 | 4 | GO:0005068 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 2.88e-06 | 66 | 278 | 8 | GO:0007019 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | CDHR5 PVR NECTIN2 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 ROBO1 PCDHGC3 CDH7 | 9.33e-06 | 187 | 278 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | TPR SPIRE2 MAP1B DAG1 HAUS8 STARD9 KIF19 MTCL1 CAMSAP1 CEP97 WDR62 DVL1 TACC2 NCKAP5L DNAAF2 CCDC88C DNAI1 MISP MAP1S CEP72 ARHGEF2 HTT SON BORA | 4.59e-05 | 720 | 278 | 24 | GO:0000226 |
| GeneOntologyBiologicalProcess | negative regulation of vesicle fusion | 4.70e-05 | 6 | 278 | 3 | GO:0031339 | |
| MousePheno | abnormal snout morphology | BCORL1 NEK1 KMT2A AGAP4 TBX15 RHOBTB3 DNAI1 SH3PXD2B KMT2D CSF1 CDK13 ROBO1 RERE AGAP7P PRDM16 AGAP6 | 1.05e-05 | 257 | 242 | 16 | MP:0000443 |
| MousePheno | abnormal telencephalon morphology | ATXN2L ATP7B MAP1B MYCBP2 ZNF423 FRS2 DAG1 PHGDH NEK1 CAMSAP1 WDR62 CDON TCF20 GPRIN3 MED1 PRX ZIC3 EPG5 DNAAF2 COL18A1 NCOR2 VAC14 KMT2D CSF1 CELSR3 CELSR2 TRIM9 STON2 ROBO1 RERE TBR1 HTT | 1.10e-05 | 812 | 242 | 32 | MP:0000787 |
| MousePheno | abnormal lateral ventricle morphology | MAP1B MYCBP2 ZNF423 DAG1 PHGDH NEK1 CDON DNAAF2 COL18A1 VAC14 CELSR2 HTT | 2.83e-05 | 164 | 242 | 12 | MP:0000823 |
| MousePheno | abnormal brain ventricle morphology | MAP1B MYCBP2 ZNF423 DAG1 PHGDH NEK1 KIF19 CDON DNAAF2 CCDC88C DNAI1 COL18A1 VAC14 CELSR2 PRDM16 HTT | 3.91e-05 | 286 | 242 | 16 | MP:0000822 |
| Domain | FN3 | CMYA5 IL22RA1 PTPRC PTPRD PTPRJ PTPRZ1 RIMBP3C CDON RIMBP3 TRIM9 ROBO1 LRRN4 RIMBP3B | 8.33e-06 | 199 | 275 | 13 | PS50853 |
| Domain | Cadherin-like | DAG1 CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 8.42e-06 | 116 | 275 | 10 | IPR015919 |
| Domain | FN3_dom | CMYA5 IL22RA1 PTPRC PTPRD PTPRJ PTPRZ1 RIMBP3C CDON RIMBP3 TRIM9 ROBO1 LRRN4 RIMBP3B | 1.41e-05 | 209 | 275 | 13 | IPR003961 |
| Domain | - | ILDR2 MYCBP2 DAG1 SEMA3G CMYA5 IL22RA1 PTPRC PTPRD PTPRJ PTPRZ1 PVR NECTIN2 RIMBP3C CDON ICAM3 LAIR2 RIMBP3 HAVCR2 TRIM9 NCAN CEACAM16 ROBO1 LRRN4 BCAM RIMBP3B | 1.75e-05 | 663 | 275 | 25 | 2.60.40.10 |
| Domain | Cadherin_CS | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 3.37e-05 | 109 | 275 | 9 | IPR020894 |
| Domain | CADHERIN_1 | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 4.48e-05 | 113 | 275 | 9 | PS00232 |
| Domain | - | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 4.80e-05 | 114 | 275 | 9 | 2.60.40.60 |
| Domain | CADHERIN_2 | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 4.80e-05 | 114 | 275 | 9 | PS50268 |
| Domain | Ig-like_fold | ILDR2 MYCBP2 DAG1 SEMA3G CMYA5 IL22RA1 PTPRC PTPRD PTPRJ PTPRZ1 PVR NECTIN2 RIMBP3C CDON ICAM3 LAIR2 RIMBP3 HAVCR2 TRIM9 NCAN CEACAM16 ROBO1 LRRN4 BCAM RIMBP3B | 4.90e-05 | 706 | 275 | 25 | IPR013783 |
| Domain | CA | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 5.15e-05 | 115 | 275 | 9 | SM00112 |
| Domain | Cadherin | CDHR5 PCDHGB6 PCDHGA7 PCDHGA3 PCDHAC1 CELSR3 CELSR2 PCDHGC3 CDH7 | 6.30e-05 | 118 | 275 | 9 | IPR002126 |
| Domain | PH_dom-like | FRS2 GAB2 TYK2 CCM2 TBC1D4 OSBPL10 AGAP4 FGD3 MAPK8IP1 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P AGAP6 PLCE1 PSD4 | 6.54e-05 | 426 | 275 | 18 | IPR011993 |
| Domain | SET_dom | 8.90e-05 | 50 | 275 | 6 | IPR001214 | |
| Domain | SET | 8.90e-05 | 50 | 275 | 6 | PS50280 | |
| Domain | FN3 | CMYA5 PTPRC PTPRD PTPRJ PTPRZ1 RIMBP3C CDON TRIM9 ROBO1 LRRN4 RIMBP3B | 9.69e-05 | 185 | 275 | 11 | SM00060 |
| Domain | Cadherin_tail | 1.98e-04 | 37 | 275 | 5 | PF15974 | |
| Domain | Cadherin_CBD | 1.98e-04 | 37 | 275 | 5 | IPR031904 | |
| Domain | DVL-1 | 2.16e-04 | 2 | 275 | 2 | IPR008340 | |
| Domain | - | FRS2 GAB2 CCM2 TBC1D4 OSBPL10 AGAP4 FGD3 MAPK8IP1 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP6 PLCE1 PSD4 | 2.39e-04 | 391 | 275 | 16 | 2.30.29.30 |
| Domain | PH | TEX2 GAB2 OSBPL10 AGAP4 FGD3 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P AGAP6 PSD4 | 2.58e-04 | 278 | 275 | 13 | SM00233 |
| Domain | Cadherin | 2.69e-04 | 113 | 275 | 8 | PF00028 | |
| Domain | PH_domain | TEX2 GAB2 OSBPL10 AGAP4 FGD3 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P AGAP6 PSD4 | 2.76e-04 | 280 | 275 | 13 | IPR001849 |
| Domain | Cadherin_C | 3.64e-04 | 42 | 275 | 5 | IPR032455 | |
| Domain | Cadherin_C_2 | 3.64e-04 | 42 | 275 | 5 | PF16492 | |
| Domain | SET | 5.58e-04 | 46 | 275 | 5 | SM00317 | |
| Domain | PH | GAB2 OSBPL10 AGAP4 FGD3 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P PSD4 | 6.09e-04 | 229 | 275 | 11 | PF00169 |
| Domain | Phe_ZIP | 6.42e-04 | 3 | 275 | 2 | PF08916 | |
| Domain | Phe_ZIP | 6.42e-04 | 3 | 275 | 2 | IPR015012 | |
| Domain | MAP1 | 6.42e-04 | 3 | 275 | 2 | IPR026074 | |
| Domain | SH2B | 6.42e-04 | 3 | 275 | 2 | IPR030523 | |
| Domain | fn3 | 6.79e-04 | 162 | 275 | 9 | PF00041 | |
| Domain | PH_DOMAIN | GAB2 OSBPL10 AGAP4 FGD3 ARHGEF5 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P AGAP6 PSD4 | 9.24e-04 | 279 | 275 | 12 | PS50003 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | DAG1 ADAMTSL4 MUC20 MUC16 ADAMTS13 MUC12 ADAMTS7 ADAMTS14 MUC1 | 3.44e-07 | 68 | 193 | 9 | M27303 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | DAG1 ADAMTSL4 SDC1 MUC20 MUC16 ADAMTS13 MUC12 ADAMTS7 NCAN ADAMTS14 MUC1 | 4.27e-06 | 143 | 193 | 11 | M27275 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | DAG1 ADAMTSL4 MUC20 MUC16 ADAMTS13 MUC12 ADAMTS7 ADAMTS14 MUC1 | 2.13e-05 | 111 | 193 | 9 | M27416 |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 5.45e-05 | 16 | 193 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 7.05e-05 | 17 | 193 | 4 | M27412 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.25e-04 | 109 | 193 | 8 | MM15164 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | CYP21A2 DAG1 ADAMTSL4 SDC1 MUC20 MUC16 ADAMTS13 MUC12 ADAMTS7 NCAN ADAMTS14 MUC1 | 1.72e-04 | 250 | 193 | 12 | M27554 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ATXN2L SPIRE2 MAP1B MYCBP2 TEX2 ATG13 KIAA0232 TSC2 ANKRD27 GAB2 HAUS8 NEK1 PANK2 TBC1D4 STARD9 SRGAP1 NECTIN2 MAP3K9 OSBPL10 FAM83G KMT2A MTCL1 CAMSAP1 WDR62 TCF20 CAMKK1 ARHGEF5 PSD3 CRTC1 MLXIP NCKAP5L TRAK1 CCDC88C NHSL1 SH3PXD2B VPS13D FXR1 TRIM9 PHACTR4 MEPCE ARHGEF2 TMCC1 | 1.44e-20 | 861 | 284 | 42 | 36931259 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SPIRE2 MYCBP2 TSC2 WASHC2A CASZ1 TYK2 PRR12 RHPN1 FASN TMCC2 SCN5A CACNA1H ULK1 CAMSAP1 FRAS1 B4GALNT4 HECTD4 DVL1 HIP1R REV3L MLXIP SH2B2 BAHD1 KCNH3 TRAK1 CCDC88C NHSL1 NCOR2 VAC14 SH3PXD2B KMT2D PWWP2B SYNE3 CELSR3 CELSR2 MAP1S ADAMTS7 CDK13 ZNF335 BCAM ARHGEF2 CABIN1 PRDM16 HTT | 3.59e-18 | 1105 | 284 | 44 | 35748872 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR UBR1 ATXN2L MYCBP2 DAXX FASN TBC1D4 PTPRC USP42 KMT2A WDR62 SEC16B NCAPD3 TCF20 MED1 NCOR2 KMT2D PWWP2B MAP1S STC2 CDK13 ZNF335 PHACTR4 TJAP1 RERE ARHGEF2 CCDC9 SON | 6.32e-11 | 774 | 284 | 28 | 15302935 |
| Pubmed | ATG13 KIAA0232 ZNF423 WASHC2A CRACD STARD9 CACNA1H MTCL1 ULK1 FRAS1 TCF20 ZSWIM5 DLGAP4 PSD3 MLXIP TRAK1 EPG5 RERE SON PLCE1 | 2.10e-10 | 407 | 284 | 20 | 12693553 | |
| Pubmed | TPR MYCBP2 BCORL1 PRR12 NEK1 FASN TOX4 TBC1D4 CAMSAP1 WDR62 TSHZ3 RBM11 TCF20 DVL1 CRTC1 MORC4 NCOR2 KMT2D FOXP1 RERE | 3.35e-10 | 418 | 284 | 20 | 34709266 | |
| Pubmed | HECW1 CTIF CASZ1 PRR12 NEK1 TOX4 TMCC2 PRUNE2 SEC16B RNF213 GPRIN3 SH2B1 PRX CCDC88C VPS13D CEP72 CDK13 N4BP1 PPP6R2 PRDM16 TMCC1 | 9.76e-10 | 493 | 284 | 21 | 15368895 | |
| Pubmed | TEX2 WASHC2A NEK1 TBC1D4 MTCL1 CAMSAP1 CEP97 WDR62 SNX29 TRAK1 NHSL1 MISP VPS13D ROBO1 | 2.29e-09 | 209 | 284 | 14 | 36779422 | |
| Pubmed | The TRIM9/TRIM67 neuronal interactome reveals novel activators of morphogenesis. | RTN3 CTIF SRGAP1 CAMSAP1 AGAP4 DVL1 NCKAP5L NHSL1 SH3PXD2B TRIM9 ARHGEF2 AGAP7P PPP6R2 AGAP6 | 3.95e-09 | 218 | 284 | 14 | 33378226 |
| Pubmed | DENND2A TEX2 ANKRD27 SEPTIN8 ZBTB5 AMOTL2 AGAP4 AKAP6 NCAPD3 PITRM1 RHOBTB3 HECTD4 HIP1R KIAA1549 CRTC1 BAHD1 CELSR3 TRIM9 AGAP7P AGAP6 | 1.83e-08 | 529 | 284 | 20 | 14621295 | |
| Pubmed | TPR ATXN2L HECW1 MAP1B MYCBP2 TEX2 DAG1 RTN3 WASHC2A PHGDH SEPTIN8 FRRS1L TMCC2 CAMSAP1 VARS1 MAPK8IP1 CACNB4 DTNA DLGAP4 DVL1 PSD3 HIP1R TACC2 NHSL1 CELSR2 MAP1S TRIM9 SMPD2 PPP6R2 TMCC1 | 2.12e-08 | 1139 | 284 | 30 | 36417873 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MAP1B MYCBP2 ATG13 KIAA0232 RTN3 CTIF CASZ1 TYK2 TBC1D4 PTPRJ PVR NECTIN2 CACNA1H CREB3L2 PRUNE2 TCF3 DTNA HECTD4 RNF213 IDE SNX29 SH2B1 COL18A1 NCOR2 PWWP2B CDK13 TJAP1 FOXP1 VGLL4 RERE PMF1 TMCC1 GLIS1 HTT MAF | 2.27e-08 | 1489 | 284 | 35 | 28611215 |
| Pubmed | A census of human transcription factors: function, expression and evolution. | NR4A1 HMX2 IRX4 STAT6 TOX4 KMT2A CREB3L2 TBX15 TSHZ3 TCF3 TCF12 FOXN4 KIAA1549 POU4F3 MLXIP PRDM4 KMT2D ZNF335 HEY2 FOXP1 DMRTA1 PAX4 RERE TBR1 GLIS1 MAF | 3.83e-08 | 908 | 284 | 26 | 19274049 |
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | ATXN2L HECW1 MYCBP2 KIAA0232 ZNF423 RTN3 TSC2 FBLN2 CDC123 ADAMTSL4 ZNF821 DLGAP4 TACC2 FXR1 TRIM9 CEP72 TJAP1 GRIP2 TBR1 AGAP7P | 4.65e-08 | 560 | 284 | 20 | 21653829 |
| Pubmed | UBR1 MAP1B ANKRD27 TYK2 PRR12 NOP9 SUPT5H OSBPL10 KMT2A ULK1 NCAPD3 FRAS1 TCF12 ARHGEF5 RHOBTB3 TRMT2A CDK13 ARHGEF2 PPP6R2 PCDHGC3 PLCE1 | 1.15e-07 | 650 | 284 | 21 | 38777146 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.75e-07 | 18 | 284 | 5 | 18834073 | |
| Pubmed | 5.39e-07 | 3 | 284 | 3 | 26770020 | ||
| Pubmed | XIRP1 CASZ1 STAT6 SEPTIN8 KCNH6 STARD9 CCDC33 CACNA1E TCF20 PRDM4 PHACTR4 PRDM14 | 5.64e-07 | 233 | 284 | 12 | 37704626 | |
| Pubmed | MYCBP2 EYA2 TOX4 TBC1D4 OCIAD1 PTPRC PTPRD PTPRJ PTPRZ1 SUPT5H NECTIN2 PMS2 DTNA PSD3 KIAA1549 RNF213 GPRIN3 IDE NCKAP5L NHSL1 NCOR2 KMT2D CEP72 ROBO1 ARHGEF2 PPP6R2 | 6.15e-07 | 1049 | 284 | 26 | 27880917 | |
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | FRS2 DAG1 CDHR5 AP1AR PTPRJ NECTIN2 OSBPL10 CAMSAP1 SDC1 COL16A1 DTNA UBXN6 PSD3 KIAA1549 CELSR2 PHACTR4 STON2 PSD4 | 1.27e-06 | 569 | 284 | 18 | 30639242 |
| Pubmed | TPR HECW1 MYCBP2 TSC2 PTPRD MTCL1 CAMSAP1 MAPK8IP1 CACNA1E CACNB4 TCF20 DLGAP4 HECTD4 CCDC88C NCOR2 SH3PXD2B FXR1 CELSR2 NCAN STON2 TJAP1 ARHGEF2 CABIN1 PPP6R2 | 1.54e-06 | 963 | 284 | 24 | 28671696 | |
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | ATP7B TSC2 EYA2 CHRNA2 FBLN2 PTPRD PTPRZ1 CACNA1H ADAMTS13 PLCE1 | 1.60e-06 | 171 | 284 | 10 | 20201926 |
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 2.10e-06 | 72 | 284 | 7 | 10380929 | |
| Pubmed | RIM-BP3 is a manchette-associated protein essential for spermiogenesis. | 2.14e-06 | 4 | 284 | 3 | 19091768 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | MAP1B MYCBP2 DAG1 RTN3 TSC2 TBC1D4 PTPRJ PVR NECTIN2 WDR62 CDON CREB3L2 FAM234B NCAPD3 FRAS1 KIAA1549 RNF213 GSR COL18A1 VAC14 CELSR3 CELSR2 STC2 ROBO1 DSEL PPP6R2 HTT | 2.36e-06 | 1201 | 284 | 27 | 35696571 |
| Pubmed | 2.45e-06 | 140 | 284 | 9 | 26930384 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ATG13 KIAA0232 PKD1L1 CTIF WASHC2A SEPTIN8 HAUS8 OCIAD1 FAM83G CAMSAP1 CEP97 WDR62 CRTC1 MLXIP NCKAP5L RIMBP3 CCDC88C SH3PXD2B PHACTR4 ARHGEF2 PPP6R2 BORA | 2.47e-06 | 853 | 284 | 22 | 28718761 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TPR MAP1B CASZ1 CRACD FASN NOP9 PRDM10 TBC1D4 CAMSAP1 VARS1 NCAPD3 TCF12 REV3L LENG9 SH2B1 NCOR2 KMT2D FXR1 TRMT2A FOXP1 ARHGEF2 CABIN1 | 2.66e-06 | 857 | 284 | 22 | 25609649 |
| Pubmed | HECW1 MYCBP2 KIAA0232 TMCC2 AKAP6 PRUNE2 PSD3 TRIM9 CEP72 GRIP2 PRDM16 | 2.77e-06 | 225 | 284 | 11 | 12168954 | |
| Pubmed | TPR ATXN2L MAP1B MYCBP2 PHGDH NEK1 FASN TOX4 KMT2A AMOTL2 TCF20 DVL1 MED1 SH3PXD2B KMT2D PHACTR4 HTT | 3.34e-06 | 549 | 284 | 17 | 38280479 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | PDE3A MYCBP2 TSC2 FASN PANK2 TBC1D4 SRGAP1 VARS1 HECTD4 ARHGEF2 | 4.11e-06 | 190 | 284 | 10 | 15161933 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 4.29e-06 | 80 | 284 | 7 | 10716726 | |
| Pubmed | ATP7B ATG13 ANKRD27 AP1AR ULK1 PRUNE2 TACC2 SNX29 VAC14 STON2 TJAP1 HTT | 4.59e-06 | 285 | 284 | 12 | 34369648 | |
| Pubmed | 5.31e-06 | 116 | 284 | 8 | 30652415 | ||
| Pubmed | 5.32e-06 | 5 | 284 | 3 | 23872634 | ||
| Pubmed | Structure and evolution of RIM-BP genes: identification of a novel family member. | 5.32e-06 | 5 | 284 | 3 | 17855024 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | RTN3 DAXX NR4A1 WASHC2A PHGDH GAB2 SEPTIN8 HAUS8 NEK1 OCIAD1 CDC123 AMOTL2 CEP97 TCF3 TCF12 DVL1 CRTC1 MLXIP NCKAP5L TRAK1 VAC14 TJAP1 PPP6R2 BORA | 5.51e-06 | 1038 | 284 | 24 | 26673895 |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | BCORL1 CASZ1 TYK2 PRR12 SUPT5H TSHZ3 TCF20 IDE MORC4 NCKAP5L NCOR2 KMT2D FOXP1 PRDM16 | 5.95e-06 | 398 | 284 | 14 | 35016035 |
| Pubmed | 7.20e-06 | 57 | 284 | 6 | 29089450 | ||
| Pubmed | TEX2 WASHC2A HAUS8 CAMSAP1 CEP97 RBM11 NCKAP5L SH2B2 SNX29 N4BP1 ARHGEF2 | 7.87e-06 | 251 | 284 | 11 | 29778605 | |
| Pubmed | MYCBP2 ZNF423 TSC2 CMYA5 STAT6 PTPRD SUPT5H ZBTB5 AMOTL2 VARS1 AKAP6 MAPK8IP1 ZNF821 RBM11 PMS2 RHOBTB3 HECTD4 CLIC6 REV3L PRDM4 SH2B1 ZIC3 CELSR3 MAP1S TRIM9 ROBO1 CABIN1 | 8.10e-06 | 1285 | 284 | 27 | 35914814 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ATXN2L BCORL1 RTN3 DAXX WASHC2A TBC1D4 SUPT5H RBM11 DTNA TACC2 MORC4 NCKAP5L GSR RIMBP3 NCOR2 PLPBP PPP6R2 | 8.22e-06 | 588 | 284 | 17 | 38580884 |
| Pubmed | MYCBP2 ZNF423 PKD1L1 DAG1 SEMA3G WASHC2A AP1AR NECTIN2 FAM83G CREB3L2 CCDC33 TSHZ3 RBM11 B4GALNT4 ZSWIM5 RHOBTB3 DLGAP4 TACC2 NCKAP5L COL18A1 NCOR2 NCAN KANK4 ADAMTS14 ARHGEF2 CDH7 | 8.74e-06 | 1215 | 284 | 26 | 15146197 | |
| Pubmed | Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette. | TEX2 ZNF423 DAG1 AGAP4 FBXO34 TCF3 TCF12 TACC2 TRAK1 NCOR2 VPS13D FOXP1 RERE ARHGEF2 AGAP7P AGAP6 | 1.03e-05 | 536 | 284 | 16 | 15840001 |
| Pubmed | Dystroglycan is a scaffold for extracellular axon guidance decisions. | 1.06e-05 | 6 | 284 | 3 | 30758284 | |
| Pubmed | TEX2 ZNF423 DAG1 AGAP4 FBXO34 TCF3 TCF12 TACC2 TRAK1 NCOR2 VPS13D FOXP1 RERE ARHGEF2 AGAP7P AGAP6 | 1.07e-05 | 538 | 284 | 16 | 10512203 | |
| Pubmed | ATXN2L ATP7B MYCBP2 TEX2 WASHC2A HAUS8 MEX3A OCIAD1 CAMSAP1 VARS1 WDR62 TCF20 RNF213 NCKAP5L FXR1 ROBO1 PLPBP N4BP1 ARHGEF2 | 1.13e-05 | 733 | 284 | 19 | 34672954 | |
| Pubmed | CASZ1 PRR12 KMT2A TCF20 MED1 MORC4 TAF6L KMT2D MEPCE FOXP1 RERE | 1.45e-05 | 268 | 284 | 11 | 33640491 | |
| Pubmed | XIRP1 SPIRE2 MAP1B BCORL1 NEK1 USP42 RIMBP3C MTCL1 FBXO34 FLG NCAPD3 PMS2 COL16A1 LENG9 NHSL1 SYNE3 ZNF335 TBR1 | 1.74e-05 | 689 | 284 | 18 | 36543142 | |
| Pubmed | ILDR2 ATXN2L DENND2A MAP1B RTN3 NDUFA8 PHGDH SEPTIN8 CRACD FASN PTPRZ1 OSBPL10 KMT2A VARS1 MAPK8IP1 CACNB4 DLGAP4 PSD3 KIAA1549 NHSL1 MISP FXR1 MAP1S TRIM9 NCAN STON2 ARHGEF2 PPP6R2 | 2.00e-05 | 1431 | 284 | 28 | 37142655 | |
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 2.00e-05 | 139 | 284 | 8 | 16985003 | |
| Pubmed | 2.14e-05 | 102 | 284 | 7 | 9734811 | ||
| Pubmed | 2.28e-05 | 103 | 284 | 7 | 10819331 | ||
| Pubmed | ZNF142 BCORL1 CSMD2 CASZ1 MTCL1 NCAPD3 RBM11 TCF20 MUC16 IDE REV3L MED1 MORC4 NCOR2 KMT2D CEP72 ARHGEF2 | 2.33e-05 | 638 | 284 | 17 | 31182584 | |
| Pubmed | SUMOylation of DDX39A Alters Binding and Export of Antiviral Transcripts to Control Innate Immunity. | DENND2A ACRV1 PKD1L1 EYA2 NR4A1 CMYA5 GAB2 PTPRZ1 MUC20 FAM234B PCBP3 OLFML2B ICAM3 CXCL16 TACC2 JSRP1 DNAAF2 OVGP1 DACT3 PMF1 PSD4 | 2.40e-05 | 915 | 284 | 21 | 32393512 |
| Pubmed | 2.84e-05 | 22 | 284 | 4 | 19050759 | ||
| Pubmed | EYA2 WASHC2A CASZ1 RHPN1 KMT2A ULK1 ZNF821 TCF3 PMS2 PCBP3 TCF12 COL16A1 FOXN4 DTNA DVL1 PSD3 TACC2 GSR ZIC3 NCOR2 ROBO1 PMF1 | 3.18e-05 | 1006 | 284 | 22 | 15226823 | |
| Pubmed | ATXN2L MAP1B MYCBP2 TEX2 RTN3 CACNA1E CACNB4 CAMKK1 DLGAP4 ARHGEF2 PPP6R2 HTT | 3.25e-05 | 347 | 284 | 12 | 17114649 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 3.27e-05 | 74 | 284 | 6 | 10817752 | |
| Pubmed | MYCBP2 ANKRD27 TOX4 PTPRC CDC123 SUPT5H CAMSAP1 MORC4 PRDM4 TRAK1 EPG5 ZNF557 NCOR2 KMT2D CDK13 SON | 3.35e-05 | 591 | 284 | 16 | 15231748 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF423 BCORL1 PRR12 KMT2A TSHZ3 TCF20 MORC4 NCOR2 KMT2D FOXP1 RERE PRDM16 | 3.63e-05 | 351 | 284 | 12 | 38297188 |
| Pubmed | 3.81e-05 | 76 | 284 | 6 | 27542412 | ||
| Pubmed | 4.10e-05 | 77 | 284 | 6 | 10835267 | ||
| Pubmed | 4.36e-05 | 9 | 284 | 3 | 9828134 | ||
| Pubmed | 4.36e-05 | 9 | 284 | 3 | 24121790 | ||
| Pubmed | GGAPs, a new family of bifunctional GTP-binding and GTPase-activating proteins. | 4.36e-05 | 9 | 284 | 3 | 12640130 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | MYCBP2 PKD1L1 MTCL1 CAMSAP1 SEC16B CRTC1 VAC14 CELSR3 MAP1S CDK13 MTBP SON | 4.76e-05 | 361 | 284 | 12 | 26167880 |
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | NR4A1 HMX2 TBX15 ZNF821 TCF12 POU4F3 ZBTB12 PRDM4 ZIC3 HEY2 FOXP1 DMRTA1 PAX4 GLIS1 MAF | 4.80e-05 | 544 | 284 | 15 | 28473536 |
| Pubmed | 5.57e-05 | 257 | 284 | 10 | 16335952 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | LDLRAD3 SCN10A CAMSAP1 PRUNE2 TSHZ3 ARHGEF5 PRDM4 SH2B1 PRX NCOR2 MAP1S STON2 SON | 6.11e-05 | 430 | 284 | 13 | 35044719 |
| Pubmed | AGAP1/AP-3-dependent endocytic recycling of M5 muscarinic receptors promotes dopamine release. | 6.20e-05 | 10 | 284 | 3 | 20664521 | |
| Pubmed | Celsr3 is required in motor neurons to steer their axons in the hindlimb. | 6.20e-05 | 10 | 284 | 3 | 25108913 | |
| Pubmed | Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus. | 6.64e-05 | 2 | 284 | 2 | 28258196 | |
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 22643886 | ||
| Pubmed | Increased CD112 expression in methylcholanthrene-induced tumors in CD155-deficient mice. | 6.64e-05 | 2 | 284 | 2 | 25384044 | |
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 19452222 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 16194893 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 10958665 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 20154672 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 15047701 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 11559707 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 33561653 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 10790539 | ||
| Pubmed | Reduced Expression of Foxp1 as a Contributing Factor in Huntington's Disease. | 6.64e-05 | 2 | 284 | 2 | 28550168 | |
| Pubmed | E2A and HEB are required to block thymocyte proliferation prior to pre-TCR expression. | 6.64e-05 | 2 | 284 | 2 | 17442955 | |
| Pubmed | Functional characterization of TBR1 variants in neurodevelopmental disorder. | 6.64e-05 | 2 | 284 | 2 | 30250039 | |
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 25531720 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 28393090 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 23687433 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 22589249 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 22805490 | ||
| Pubmed | Common genetic variants at 1q22 and 10q23 and gastric cancer susceptibility in a Korean population. | 6.64e-05 | 2 | 284 | 2 | 24254309 | |
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 24423662 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 23580664 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 12391177 | ||
| Pubmed | Mutations in SCN10A are responsible for a large fraction of cases of Brugada syndrome. | 6.64e-05 | 2 | 284 | 2 | 24998131 | |
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 38839978 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 8644734 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 24360055 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 25644604 | ||
| Pubmed | 6.64e-05 | 2 | 284 | 2 | 16546275 | ||
| Interaction | YWHAH interactions | ATXN2L SPIRE2 MYCBP2 TEX2 ATG13 KIAA0232 TSC2 ANKRD27 GAB2 HAUS8 NEK1 PANK2 TBC1D4 CDC123 STARD9 SRGAP1 NECTIN2 MAP3K9 OSBPL10 FAM83G KMT2A MTCL1 AMOTL2 CAMSAP1 WDR62 TCF20 CAMKK1 ARHGEF5 HECTD4 PSD3 CRTC1 MLXIP MED1 NCKAP5L TRAK1 CCDC88C NHSL1 SH3PXD2B VPS13D FXR1 PHACTR4 MEPCE MTBP ARHGEF2 TMCC1 HTT | 2.28e-11 | 1102 | 281 | 46 | int:YWHAH |
| Interaction | YWHAG interactions | ATXN2L SPIRE2 MYCBP2 ATG13 KIAA0232 RTN3 TSC2 GAB2 CRACD HAUS8 NEK1 PANK2 TBC1D4 CDC123 STARD9 SRGAP1 NECTIN2 MAP3K9 OSBPL10 FAM83G KMT2A MTCL1 ULK1 AMOTL2 CAMSAP1 CEP97 WDR62 BNIP5 CAMKK1 ARHGEF5 HECTD4 PSD3 CRTC1 MLXIP NCKAP5L TRAK1 CCDC88C NHSL1 VPS13D FXR1 PHACTR4 MEPCE MTBP ARHGEF2 TMCC1 HTT SON PSD4 | 1.32e-10 | 1248 | 281 | 48 | int:YWHAG |
| Interaction | YWHAB interactions | ATXN2L SPIRE2 MYCBP2 ATG13 KIAA0232 RTN3 TSC2 GAB2 NEK1 PANK2 TBC1D4 CDC123 STARD9 SRGAP1 NECTIN2 MAP3K9 FAM83G KMT2A MTCL1 AMOTL2 CAMSAP1 WDR62 NCAPD3 CAMKK1 ARHGEF5 HECTD4 PSD3 CRTC1 MLXIP NCKAP5L TRAK1 CCDC88C NHSL1 VPS13D PHACTR4 MEPCE MTBP ARHGEF2 TMCC1 HTT SON | 8.31e-10 | 1014 | 281 | 41 | int:YWHAB |
| Interaction | YWHAQ interactions | TPR ATXN2L PDE3A SPIRE2 MYCBP2 TSC2 MEFV GAB2 NEK1 FASN PANK2 TBC1D4 USP42 CDC123 STARD9 SRGAP1 NECTIN2 MAP3K9 FAM83G KMT2A AMOTL2 CAMSAP1 VARS1 WDR62 TCF3 CAMKK1 ARHGEF5 HECTD4 PSD3 CRTC1 MLXIP MED1 NCKAP5L TRAK1 CCDC88C NHSL1 VPS13D PHACTR4 MEPCE ARHGEF2 CABIN1 TMCC1 HTT | 1.40e-09 | 1118 | 281 | 43 | int:YWHAQ |
| Interaction | TOP3B interactions | SPIRE2 MYCBP2 TSC2 CTIF WASHC2A CASZ1 PHGDH TYK2 PRR12 RHPN1 FASN TMCC2 SCN5A CACNA1H ULK1 CAMSAP1 ADAMTSL4 RBM11 FRAS1 B4GALNT4 HECTD4 DVL1 HIP1R REV3L MLXIP SH2B2 BAHD1 KCNH3 TRAK1 CCDC88C NHSL1 NCOR2 VAC14 SH3PXD2B KMT2D FXR1 PWWP2B SYNE3 CELSR3 CELSR2 MAP1S ADAMTS7 CDK13 ZNF335 BCAM ARHGEF2 CABIN1 PRDM16 HTT | 9.75e-09 | 1470 | 281 | 49 | int:TOP3B |
| Interaction | YWHAZ interactions | ATXN2L SPIRE2 MYCBP2 TEX2 ATG13 KIAA0232 TSC2 NR4A1 ANKRD27 GAB2 CRACD NEK1 PANK2 TBC1D4 CDC123 STARD9 SRGAP1 NECTIN2 MAP3K9 FAM83G KMT2A ULK1 CAMSAP1 WDR62 BNIP5 NCAPD3 ARHGEF5 HECTD4 PSD3 HIP1R CRTC1 TACC2 MLXIP NCKAP5L TRAK1 CCDC88C NHSL1 VPS13D PHACTR4 MEPCE MTBP ARHGEF2 TMCC1 HTT PSD4 | 2.18e-08 | 1319 | 281 | 45 | int:YWHAZ |
| Interaction | YWHAE interactions | ATXN2L SPIRE2 MAP1B MYCBP2 KIAA0232 INSIG1 TSC2 ANKRD27 GAB2 CRACD NEK1 PANK2 TBC1D4 SRGAP1 MAP3K9 FAM83G KMT2A ULK1 AMOTL2 CAMSAP1 WDR62 BNIP5 CAMKK1 PITRM1 ARHGEF5 PSD3 CRTC1 TACC2 MLXIP NCKAP5L TRAK1 CCDC88C NCOR2 CDK13 PHACTR4 MEPCE PLPBP MTBP ARHGEF2 TMCC1 HTT PSD4 | 1.20e-07 | 1256 | 281 | 42 | int:YWHAE |
| Interaction | RYK interactions | DVL1P1 FRS2 DAG1 SEPTIN8 PTPRD PVR NECTIN2 CDON PCDHGA7 DVL1 CELSR3 CELSR2 BCAM PCDHGC3 | 1.77e-06 | 212 | 281 | 14 | int:RYK |
| Interaction | SOX7 interactions | 1.89e-05 | 82 | 281 | 8 | int:SOX7 | |
| Interaction | GSC interactions | 2.91e-05 | 87 | 281 | 8 | int:GSC | |
| Cytoband | 5q31 | 8.51e-05 | 115 | 284 | 6 | 5q31 | |
| GeneFamily | CD molecules|Mucins | 1.61e-06 | 21 | 179 | 5 | 648 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | GAB2 OSBPL10 AGAP4 FGD3 PSD3 SH2B2 SH2B1 ARHGEF2 AGAP7P AGAP6 PSD4 | 6.71e-06 | 206 | 179 | 11 | 682 |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 2.00e-05 | 17 | 179 | 4 | 1197 | |
| GeneFamily | Fibronectin type III domain containing | 3.13e-05 | 160 | 179 | 9 | 555 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 4.87e-05 | 21 | 179 | 4 | 813 | |
| GeneFamily | Transmembrane and coiled-coil domain containing | 2.91e-04 | 3 | 179 | 2 | 774 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 2.91e-04 | 3 | 179 | 2 | 913 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily C|CELSR cadherins | 2.91e-04 | 3 | 179 | 2 | 1189 | |
| GeneFamily | Clustered protocadherins | 4.28e-04 | 64 | 179 | 5 | 20 | |
| GeneFamily | Immunoglobulin like domain containing | 6.88e-04 | 193 | 179 | 8 | 594 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 8.23e-04 | 19 | 179 | 3 | 50 | |
| GeneFamily | Calcium voltage-gated channel subunits | 2.10e-03 | 26 | 179 | 3 | 253 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF142 ZNF423 CASZ1 PRDM10 ZBTB5 ZNF438 ZNF821 TSHZ3 ZBTB12 PRDM4 ZIC3 ZNF557 ZNF335 PRDM16 PRDM14 GLIS1 | 2.11e-03 | 718 | 179 | 16 | 28 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.35e-03 | 9 | 179 | 2 | 1203 | |
| GeneFamily | ArfGAPs | 4.19e-03 | 33 | 179 | 3 | 395 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 4.56e-03 | 34 | 179 | 3 | 487 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | TPR MAP1B SEMA3G ANKRD27 RHPN1 SEPTIN8 KCNH6 FRRS1L SCN5A KCNN3 CREB3L2 TCF3 FRAS1 CACNB4 OLFML2B KCP KIAA1549 ZBTB12 CCDC88C SH3PXD2B EFNA4 CELSR3 STC2 ROBO1 MTBP RERE BCAM ARHGEF2 PRDM16 BORA | 4.18e-08 | 891 | 283 | 30 | M45033 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | SPAG4 MAP1B TEX2 ATG13 HMX2 LDLRAD3 PTPRZ1 SRGAP1 TMCC2 ULK1 AMOTL2 SDC1 SEC16B FAM234B TCF12 COL16A1 DTNA RHOBTB3 DLGAP4 HECTD4 HIP1R KIAA1549 PMEL NHSL1 SPATS2L CSF1 NCAN TJAP1 FOXP1 SMPD2 CABIN1 HTT MAF | 1.32e-07 | 1102 | 283 | 33 | M2369 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | SPAG4 MAP1B TEX2 ATG13 HMX2 LDLRAD3 PTPRZ1 SRGAP1 TMCC2 ULK1 AMOTL2 SDC1 SEC16B FAM234B TCF12 COL16A1 DTNA RHOBTB3 DLGAP4 HECTD4 HIP1R KIAA1549 PMEL NHSL1 SPATS2L CSF1 NCAN TJAP1 FOXP1 SMPD2 CABIN1 HTT MAF | 2.07e-07 | 1124 | 283 | 33 | MM1070 |
| Coexpression | GSE14026_TH1_VS_TH17_UP | SEMA3G MEFV FASN CAMSAP1 CACNB4 PCDHAC1 PRDM4 BAHD1 KCNH3 TRMT2A NCAN ROBO1 GRIP2 | 3.01e-07 | 200 | 283 | 13 | M3356 |
| Coexpression | GSE8515_IL1_VS_IL6_4H_STIM_MAC_DN | MEFV PRDM10 SCN5A FRAS1 PNLIPRP2 ADAMTS13 SH2B2 CEMP1 MISP VGLL4 CCDC9 | 9.20e-06 | 194 | 283 | 11 | M5767 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NEUROENDOCRINE_CELL | MAP1B CASZ1 KCNH6 SRGAP1 KIF19 CACNA1H PRUNE2 MAPK8IP1 DTNA TACC2 KCNH3 ROBO1 | 9.61e-06 | 233 | 283 | 12 | M45712 |
| Coexpression | GSE35543_IN_VIVO_NTREG_VS_CONVERTED_EX_ITREG_DN | PDE3A ZNF423 RHPN1 SCN10A SDC1 TACC2 POU4F3 MORC4 DNAI1 DACT3 GLIS1 | 1.17e-05 | 199 | 283 | 11 | M9434 |
| Coexpression | GSE13306_TREG_RA_VS_TCONV_RA_UP | MAP1B KIAA0232 INSIG1 COPRS PRDM10 USP42 CDON IDE CCDC88C CELSR2 ARHGEF2 | 1.23e-05 | 200 | 283 | 11 | M3226 |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_ROSIGLITAZONE_STIM_UP | EYA2 TBC1D4 FBXO34 OLFML2B RHOBTB3 MLXIP VPS13D SPATS2L STON2 VGLL4 MAF | 1.23e-05 | 200 | 283 | 11 | M7978 |
| Coexpression | GSE40274_FOXP3_VS_FOXP3_AND_GATA1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | ZNF423 NR4A1 TBC1D4 USP42 TMCC2 MTCL1 TBX15 PRUNE2 TACC2 SH3PXD2B EFNA4 | 1.23e-05 | 200 | 283 | 11 | M9186 |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | EYA2 LDLRAD3 PTPRD CDC123 KCNN3 SDC1 CEP97 CDON TBX15 PRUNE2 TSHZ3 TCF12 TCF20 OLFML2B PSD3 SNX29 COL18A1 NCOR2 SYNE3 SPATS2L STC2 KANK4 FOXP1 RERE ADAMTS14 PLCE1 MAF | 1.52e-05 | 1009 | 283 | 27 | M157 |
| Coexpression | PEREZ_TP53_TARGETS | ILDR2 KIAA0232 TSC2 F8 CRACD PTPRJ TMCC2 ZBTB5 FAM83G MTCL1 ULK1 FBXO34 FGD3 CREB3L2 FLG HECTD4 HIP1R KCP KIAA1549 RNF213 MLXIP TRAK1 RIMBP3 COL18A1 EFNA4 SYNE3 CELSR2 ADAMTS7 SEC14L5 MAF | 1.87e-05 | 1201 | 283 | 30 | M4391 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | SPIRE2 MAP1B TEX2 BCORL1 CASZ1 KCNH6 AP1AR SRGAP1 KIF19 KCNN3 CACNA1H MAPK8IP1 RBM11 GPRIN3 BAHD1 STON2 | 1.97e-05 | 429 | 283 | 16 | M45694 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | MAP1B ATG13 NEK1 TOX4 PTPRD SDC1 PRUNE2 TCF3 PMS2 COL16A1 DTNA DLGAP4 SNX29 TRAK1 PAX4 PPP6R2 MUC1 | 2.22e-05 | 482 | 283 | 17 | M12144 |
| Coexpression | LIAO_METASTASIS | ATXN2L SPAG4 PHF19 MAP1B BCORL1 USP42 MTCL1 TCF3 DTNA DLGAP4 SH2B1 PWWP2B CDK13 ROBO1 SMPD2 VGLL4 ARHGEF2 TMCC1 | 2.69e-05 | 540 | 283 | 18 | M13809 |
| Coexpression | PRC2_EED_DN.V1_DN | INSIG1 FRS2 TSC2 FASN VARS1 PCDHGA3 MISP VAC14 TRMT2A PCDHGC3 | 5.06e-05 | 193 | 283 | 10 | M2734 |
| Coexpression | GSE22886_IL2_VS_IL15_STIM_NKCELL_UP | IRX4 PTPRZ1 MAP3K9 FRAS1 PCBP3 PCDHGB6 PSD3 POU4F3 ADAMTS7 SEC14L5 | 5.76e-05 | 196 | 283 | 10 | M4514 |
| Coexpression | GSE13484_UNSTIM_VS_3H_YF17D_VACCINE_STIM_PBMC_UP | 6.54e-05 | 199 | 283 | 10 | M3257 | |
| Coexpression | GSE3982_BCELL_VS_BASOPHIL_UP | SEMA3G NDUFA8 MTCL1 TCF3 OLFML2B PHACTR4 SMPD2 CCDC9 SEC14L5 PSD4 | 6.54e-05 | 199 | 283 | 10 | M5538 |
| Coexpression | GSE28737_BCL6_HET_VS_BCL6_KO_MARGINAL_ZONE_BCELL_UP | MYCBP2 PTPRZ1 FRRS1L ZBTB5 CCDC33 FOXN4 MUC16 JSRP1 N4BP1 RERE | 6.82e-05 | 200 | 283 | 10 | M9348 |
| Coexpression | GSE27786_BCELL_VS_MONO_MAC_UP | 6.82e-05 | 200 | 283 | 10 | M4817 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 7.03e-05 | 162 | 283 | 9 | M45037 | |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | EYA2 CMYA5 MTCL1 FRAS1 CACNB4 PITRM1 KIAA1549 CLIC6 SNX29 ADAMTS14 CDH7 | 7.58e-05 | 244 | 283 | 11 | M40312 |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | TEX2 DAG1 EYA2 PTPRD KCNN3 CAMSAP1 PITRM1 OLFML2B MORC4 COL18A1 SPATS2L STC2 ARHGEF2 | 9.25e-05 | 340 | 283 | 13 | M2012 |
| Coexpression | WHITFIELD_CELL_CYCLE_G2 | 9.30e-05 | 168 | 283 | 9 | M2076 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN | EYA2 LDLRAD3 CDC123 KCNN3 SDC1 CDON TBX15 PRUNE2 TSHZ3 TCF20 SPATS2L KANK4 ADAMTS14 PLCE1 MAF | 9.35e-05 | 438 | 283 | 15 | M227 |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | EYA2 CDC123 SDC1 CDON TBX15 TSHZ3 TCF12 OLFML2B PSD3 SNX29 NCOR2 SPATS2L KANK4 RERE ADAMTS14 | 1.01e-04 | 441 | 283 | 15 | M172 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | MAP1B MYCBP2 INSIG1 COPRS CRACD AP1AR FASN TBC1D4 OCIAD1 PTPRJ CACNA1H CREB3L2 PRUNE2 TSHZ3 DLGAP4 HECTD4 PSD3 PRDM4 SNX29 NCOR2 FXR1 TRIM9 ROBO1 RERE | 1.05e-04 | 946 | 283 | 24 | M39169 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PULMONARY_NE_PRECURSOR_CELL | MAP1B CASZ1 GAB2 KCNH6 SRGAP1 KIF19 CACNA1H PRUNE2 MAPK8IP1 TACC2 KCNH3 ROBO1 | 1.27e-04 | 304 | 283 | 12 | M45711 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_SUBOPTIMAL_DEBULKING | ATXN2L DAG1 CDHR5 F8 PTPRD CREB3L2 MAPK8IP1 RHOBTB3 PSD3 REV3L VAC14 CSF1 TRMT2A ADAMTS7 ARHGEF2 PSD4 | 1.38e-04 | 506 | 283 | 16 | M253 |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_UP | KLHDC7B CMYA5 CASZ1 MEFV PHGDH USP42 NECTIN2 KIF19 AMOTL2 IL4I1 PRUNE2 RBM11 ZSWIM5 RNF213 SH2B2 SMTNL1 SPATS2L CSF1 STON2 N4BP1 ADAMTS14 MUC1 PRDM16 CCDC9 | 1.60e-04 | 973 | 283 | 24 | M41080 |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR | ILDR2 DAG1 RNF217 CRACD FASN FBLN2 AKAP6 BNIP5 ARHGEF5 RHOBTB3 KIAA1549 CRTC1 SH2B1 SH3PXD2B MAP1S ARHGEF2 MUC1 | 1.87e-04 | 574 | 283 | 17 | M8215 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | MAPK8IP1 ZSWIM5 DTNA TRAK1 ZIC3 CCDC88C ADAMTS7 NCAN STON2 CDH7 | 6.03e-06 | 127 | 274 | 10 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 | SPAG4 PHF19 BCORL1 DAG1 PHGDH PRR12 CRACD FASN PTPRJ NECTIN2 MAP3K9 ZBTB5 CACNA1H FBXO34 CDON MAPK8IP1 ZNF821 FAM234B FRAS1 B4GALNT4 TCF20 ZSWIM5 DTNA RHOBTB3 DVL1 ZBTB12 NCKAP5L SH2B1 CCDC88C COL18A1 EFNA4 CELSR2 STC2 STON2 PRDM16 PMF1 | 8.38e-06 | 1275 | 274 | 36 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K0 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500 | ILDR2 MAP1B EYA2 PHGDH CRACD NECTIN2 MTCL1 CEP97 CDON MAPK8IP1 ZSWIM5 DTNA CCDC88C CELSR2 STC2 STON2 DMRTA1 BCAM DSEL | 2.57e-05 | 495 | 274 | 19 | Facebase_RNAseq_e10.5_Olfactory Pit_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | ILDR2 MAP1B INSIG1 EYA2 PHGDH CRACD FBLN2 PTPRJ NECTIN2 MTCL1 CEP97 CDON CCDC33 MAPK8IP1 COL16A1 ZSWIM5 DTNA PSD3 KCP RNF213 CCDC88C CELSR2 STC2 STON2 DMRTA1 BCAM DSEL PRDM16 PSD4 | 3.15e-05 | 984 | 274 | 29 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | MAPK8IP1 ZSWIM5 DTNA TRAK1 ZIC3 CCDC88C CELSR2 ADAMTS7 NCAN STON2 CDH7 | 7.62e-05 | 205 | 274 | 11 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K5 |
| ToppCell | COVID-19-Heart-VSMC|COVID-19 / Disease (COVID-19 only), tissue and cell type | PDE3A MAP1B NR4A1 LDLRAD3 CACNA1H AKAP6 COL18A1 DACT3 HEY2 PRDM16 PLCE1 | 1.79e-08 | 175 | 284 | 11 | 1125f0d3a5b2388fa77a820dea0288e824d84a82 |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial_progenitor-epi-tip_intermediate|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | NOP9 CDON FRAS1 CACNB4 HIP1R KIAA1549 NHSL1 KMT2D PWWP2B ZNF335 MEPCE | 3.18e-08 | 185 | 284 | 11 | 636505a3d96f75d951ab42bcf8af6ae07abc732d |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | CMYA5 CASZ1 SCN5A AKAP6 PRUNE2 CACNA1E DTNA PSD3 TACC2 GRIP2 PLCE1 | 3.75e-08 | 188 | 284 | 11 | 6d249fe92d51a19da19ec14bb2262d394255d577 |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | PDE3A CMYA5 CASZ1 TBC1D4 SCN5A AKAP6 DTNA PSD3 TACC2 GRIP2 PRDM16 | 4.18e-08 | 190 | 284 | 11 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EYA2 PHGDH CACNA1H CDON CACNB4 CAMKK1 DTNA SH2B2 DACT3 KANK4 | 2.97e-07 | 183 | 284 | 10 | d67454baf0cf791a743b51afd1cb25bfb5765385 |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EYA2 PHGDH CACNA1H CDON CACNB4 CAMKK1 DTNA SH2B2 DACT3 KANK4 | 2.97e-07 | 183 | 284 | 10 | e49ac8314b6fe98426b1514ea68d646297b8bc0f |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | FRS2 FRAS1 TCF20 ZSWIM5 HECTD4 SPATS2L PHACTR4 ROBO1 RERE PPP6R2 | 3.45e-07 | 186 | 284 | 10 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | FRS2 FRAS1 TCF20 ZSWIM5 HECTD4 SPATS2L PHACTR4 ROBO1 RERE PPP6R2 | 3.45e-07 | 186 | 284 | 10 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.45e-07 | 186 | 284 | 10 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | LDLRAD3 CASZ1 CRACD FBLN2 PTPRJ CCDC33 TCF20 VGLL4 RERE CABIN1 | 3.62e-07 | 187 | 284 | 10 | 7e376831a11ee72ed87abcdac631ca46ae29c250 |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | FBLN2 PTPRD AMOTL2 TBX15 FRAS1 COL16A1 OLFML2B SYT15B HEY2 ADAMTS14 | 3.81e-07 | 188 | 284 | 10 | de6f4889e0c5f39fbbaefd85526f645c6afa09d5 |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DENND2A TBC1D4 NECTIN2 KCNN3 CACNA1E NHSL1 COL18A1 STC2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DENND2A PDE3A EYA2 PTPRD SRGAP1 PCBP3 COL16A1 PSD3 REV3L ROBO1 | 4.20e-07 | 190 | 284 | 10 | 45df8fee00f8949937863159d7aa042e72748d9b |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DENND2A TBC1D4 NECTIN2 KCNN3 CACNA1E NHSL1 COL18A1 STC2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ZNF423 F8 TBC1D4 NECTIN2 SCN5A KCNN3 COL18A1 STON2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | 26e2237f65cb43723c5da853831b40df2982d6e4 |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ZNF423 F8 TBC1D4 NECTIN2 SCN5A KCNN3 COL18A1 STON2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | a1514d2186eb4fe569971ab22dc0c17d353fb94a |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ZNF423 F8 TBC1D4 NECTIN2 SCN5A KCNN3 COL18A1 STON2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | DENND2A TBC1D4 NECTIN2 KCNN3 CACNA1E NHSL1 COL18A1 STC2 PLCE1 MAF | 4.20e-07 | 190 | 284 | 10 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | EYA2 NR4A1 FBLN2 CDON SEC16B CACNB4 COL16A1 OLFML2B GRIP2 DSEL | 5.08e-07 | 194 | 284 | 10 | 439d3f17c1f4736122b330e98add9292c7036a8e |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-muscle|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | KIF19 AMOTL2 DTNA OLFML2B RHOBTB3 TACC2 SPATS2L CEACAM16 KANK4 BCAM | 5.33e-07 | 195 | 284 | 10 | 80b973d2a23ef9b101c90e1635e68c9a3f78f65d |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | PDE3A MAP1B CACNA1H AKAP6 COL18A1 DACT3 HEY2 GRIP2 BCAM PRDM16 | 6.13e-07 | 198 | 284 | 10 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Neuronal-GABAergic_neurons|GW23 / Sample Type, Dataset, Time_group, and Cell type. | MAP1B MYCBP2 CRACD FGD3 MAPK8IP1 TSHZ3 DLGAP4 GRIP2 TMCC1 MAF | 6.71e-07 | 200 | 284 | 10 | c6bbd33bca86ac7a76a7ba704b3e141237d04549 |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.52e-06 | 170 | 284 | 9 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.76e-06 | 173 | 284 | 9 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-Plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 174 | 284 | 9 | 3f4277763e312b46ebd4401ea4a2f5d4c850c768 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-06 | 174 | 284 | 9 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | droplet-Lung-nan-21m-Lymphocytic-plasma_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 174 | 284 | 9 | fad66d1a8407574b6a835e0bdb824a53afa58650 | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-06 | 175 | 284 | 9 | 28b29f844fa46fe579ddc19039fb2d9dc5f48f3b | |
| ToppCell | droplet-Lung-21m-Hematologic-lymphocytic-plasma_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.94e-06 | 175 | 284 | 9 | ac96ca9ca309b0d72a2f5af6a3b02c7f80755750 | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.03e-06 | 176 | 284 | 9 | 5f9ae5eb45603ed0422a3a993ecdbe2ce05d6e45 | |
| ToppCell | PCW_13-14-Neuronal-Neuronal_SCP|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.13e-06 | 177 | 284 | 9 | 621dd82f1393c961d4dd7a615aa52c9df9e36336 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enteroendocrine_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | MAP1B TMCC2 CACNA1H PRUNE2 MAPK8IP1 FAM234B CELSR3 TRIM9 PAX4 | 2.23e-06 | 178 | 284 | 9 | 30ca37f70d267cc9b40ca3e211f16d30360c3e6b |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 179 | 284 | 9 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-06 | 179 | 284 | 9 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-06 | 181 | 284 | 9 | 330d4322f4c4373f706273c1f4e218b59051b7fd | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.55e-06 | 181 | 284 | 9 | 3f4d5d79c1286614514b0e8134079d6128a2a23e | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.92e-06 | 184 | 284 | 9 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.06e-06 | 185 | 284 | 9 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | KCNH6 CACNA1H HECTD4 COL18A1 SPATS2L KANK4 FOXP1 PPP6R2 PRDM16 | 3.06e-06 | 185 | 284 | 9 | 1d874608aa2062024323512f68889219471b2f00 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LDLRAD3 PTPRD CAMSAP1 ADAMTSL4 AKAP6 TSHZ3 OLFML2B SH3PXD2B MUC1 | 3.19e-06 | 186 | 284 | 9 | f73cb91e74a806858650ae97f543fc779ba4cff8 |
| ToppCell | 10x_5'_v1-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | LDLRAD3 PTPRD CAMSAP1 ADAMTSL4 AKAP6 TSHZ3 OLFML2B SH3PXD2B MUC1 | 3.19e-06 | 186 | 284 | 9 | 8694ca16c9780729f4fba67ba20e35745f1eb4e9 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | HECW1 PTPRD OSBPL10 PRUNE2 KIAA1549 HAVCR2 SPATS2L STON2 GLIS1 | 3.34e-06 | 187 | 284 | 9 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 3.34e-06 | 187 | 284 | 9 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.34e-06 | 187 | 284 | 9 | 806075c2531a7f5c1da38b85ea494a3b4b5e92ec | |
| ToppCell | RA-11._Adipocyte|World / Chamber and Cluster_Paper | 3.49e-06 | 188 | 284 | 9 | 4dac9d636e5cad4cda540b93d4bfed6b5732c880 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 3.64e-06 | 189 | 284 | 9 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.64e-06 | 189 | 284 | 9 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRD OSBPL10 MTCL1 PRUNE2 DTNA KIAA1549 HAVCR2 SPATS2L GLIS1 | 3.80e-06 | 190 | 284 | 9 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 3.80e-06 | 190 | 284 | 9 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.80e-06 | 190 | 284 | 9 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 191 | 284 | 9 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 191 | 284 | 9 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-06 | 191 | 284 | 9 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.97e-06 | 191 | 284 | 9 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 3.97e-06 | 191 | 284 | 9 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.14e-06 | 192 | 284 | 9 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.32e-06 | 193 | 284 | 9 | d1445b8bf2bab36e1a326ddb2a528151db016c7d | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-bulge_keratinocyte|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LDLRAD3 CASZ1 ADAMTSL4 SDC1 MAPK8IP1 TCF12 DLGAP4 COL18A1 FOXP1 | 4.32e-06 | 193 | 284 | 9 | eba3c70701b051bc1ed1f4db9270cb27a77ffc3e |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.32e-06 | 193 | 284 | 9 | 3ed46f5a7419ec4eddbd0df0d9b5f53aa486198b | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.32e-06 | 193 | 284 | 9 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 4.32e-06 | 193 | 284 | 9 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 284 | 9 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.50e-06 | 194 | 284 | 9 | 69bff17df4a760ccf081cf52ff04af02c14f448d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.50e-06 | 194 | 284 | 9 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 4.50e-06 | 194 | 284 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | facs-Skin-Anagen-3m-Epithelial-outer_bulge|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | LDLRAD3 CASZ1 ADAMTSL4 SDC1 MAPK8IP1 TCF12 DLGAP4 COL18A1 FOXP1 | 4.50e-06 | 194 | 284 | 9 | 5d30d3d41d5f19cdf3077cc609aa2738762cb8c5 |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | EYA2 NR4A1 RNF217 CREB3L2 PCBP3 RHOBTB3 COL18A1 NCOR2 SH3PXD2B | 4.50e-06 | 194 | 284 | 9 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 4.69e-06 | 195 | 284 | 9 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | mLN-B_cell-B_cell_IgG_Plasma|mLN / Region, Cell class and subclass | 4.89e-06 | 196 | 284 | 9 | 03b79f237e4f7ebab46b277d05377569c6342cf7 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-06 | 196 | 284 | 9 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | mLN-(2)_B_cell-(21)_B_cell_IgG_Plasma|mLN / shred on region, Cell_type, and subtype | 4.89e-06 | 196 | 284 | 9 | e8b12b046d42a58e6f4d9419ab05a5c55e764f34 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.89e-06 | 196 | 284 | 9 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.10e-06 | 197 | 284 | 9 | bb35a2b7320fda92e9cd42f536b7bd54e3a73a32 | |
| ToppCell | mild-Treg|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.10e-06 | 197 | 284 | 9 | 39800e6e83f2d333b753d121c7aeb2912b91faa2 | |
| ToppCell | LPS_only-Epithelial_alveolar|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 198 | 284 | 9 | 655df75b9692d815c7f6910275e1f684ac63bf62 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 198 | 284 | 9 | bd42c03e384e64f61b02618cf1a5440033bb04b2 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.53e-06 | 199 | 284 | 9 | 706b7de777ff86eb22e538ccd5c2987ceb6be308 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 5.53e-06 | 199 | 284 | 9 | 471738f2059e20407572d9c4cbd11812068333ea | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.53e-06 | 199 | 284 | 9 | 690a4f84b205532c4c9e5c19d5ae430d0655f421 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 5.76e-06 | 200 | 284 | 9 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | CASZ1 SRGAP1 CACNA1E SEC16B CACNB4 PSD3 KIAA1549 MUC16 MORC4 | 5.76e-06 | 200 | 284 | 9 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte-Pericyte_2|LPS_only / Treatment groups by lineage, cell group, cell type | 5.76e-06 | 200 | 284 | 9 | 69edc375d85689300d1dbc1217fedc40063ecdcb | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.82e-06 | 151 | 284 | 8 | 45392bb1c6358beff33da0ca84f7696fb5824f30 | |
| ToppCell | BAL-Mild-Myeloid-TRAM-TRAM2|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.82e-06 | 151 | 284 | 8 | 3d861285c71abe220b19a069eb9876199c6c8f39 | |
| ToppCell | COVID-Treg-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 6.41e-06 | 153 | 284 | 8 | 47c649fd4231e507f2d4654ccac61faf21a04eff | |
| ToppCell | Mild_COVID-19-Myeloid-TRAM2|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 6.72e-06 | 154 | 284 | 8 | ab648f6b29eb9e499e46cbdbaf3c5cf6b94d1f64 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1_high|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 7.05e-06 | 155 | 284 | 8 | cd2ccb4632713b4def3a1064599b78207e2e44c0 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.39e-06 | 156 | 284 | 8 | 574f761962a7dd3308bd41fc529dd3ea1b8625f8 | |
| ToppCell | PND07-28-samps-Mesenchymal-Mesothelial-Mesothelial|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 7.39e-06 | 156 | 284 | 8 | 605d95a900e1443d3f6aae163ef2e893d3293203 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.75e-06 | 157 | 284 | 8 | 275a4c6fef1fff8da2bdc48e3924ad05c5e5cfc8 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_D2|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 8.11e-06 | 158 | 284 | 8 | 74aa4f75307575ac3b2b1aa9f727753692f88742 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 8.11e-06 | 158 | 284 | 8 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-06 | 158 | 284 | 8 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.11e-05 | 165 | 284 | 8 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-05 | 167 | 284 | 8 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.22e-05 | 167 | 284 | 8 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 169 | 284 | 8 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 169 | 284 | 8 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-05 | 169 | 284 | 8 | 4e1322cc5e1733e9fb19e08f739a30206f43cea8 | |
| ToppCell | Healthy/Control-Plasmablast|World / Disease group and Cell class | 1.51e-05 | 172 | 284 | 8 | d3bfcf5d936152b71cd90f955f9331709edd979e | |
| Computational | Neighborhood of FANCG | TPR DAXX WDR62 PCBP3 DTNA BAHD1 SH2B1 KMT2D CDK13 GRIP2 RERE PMF1 | 1.09e-05 | 167 | 167 | 12 | MORF_FANCG |
| Computational | Neighborhood of RFC1 | 4.80e-05 | 109 | 167 | 9 | MORF_RFC1 | |
| Drug | Iohexol [66108-95-0]; Up 200; 4.8uM; MCF7; HT_HG-U133A | ATXN2L CTIF SEMA3G NR4A1 CHRNA2 TCF3 DTNA BAHD1 TRAK1 DNAAF2 VAC14 VPS13D CSF1 CELSR3 PHACTR4 BCAM PPP6R2 MUC1 | 5.04e-11 | 200 | 277 | 18 | 3322_UP |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | HECW1 ATG13 INSIG1 NR4A1 NECTIN2 OSBPL10 CAMSAP1 TCF3 HIP1R CRTC1 RERE ARHGEF2 MUC1 CCDC9 PSD4 | 1.94e-08 | 196 | 277 | 15 | 627_UP |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | SPAG4 INSIG1 GAB2 PVR CACNA1H WDR62 OLFML2B ADAMTS13 MLXIP TRAK1 OVGP1 TJAP1 RERE SEC14L5 | 1.29e-07 | 195 | 277 | 14 | 1539_UP |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | HECW1 ACRV1 PVR KMT2A CAMSAP1 TRAK1 TAF6L NCOR2 VPS13D CDK13 RERE BCAM SON PSD4 | 1.37e-07 | 196 | 277 | 14 | 3837_UP |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; MCF7; HT_HG-U133A | SPAG4 HECW1 IL22RA1 MAP3K9 CACNA1H CAMSAP1 ZNF821 ADAMTS13 OVGP1 CELSR3 TJAP1 BCAM ARHGEF2 PSD4 | 1.46e-07 | 197 | 277 | 14 | 7482_UP |
| Drug | Pizotifen malate [5189-11-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A | ATXN2L HECW1 INSIG1 FRS2 PVR SCN5A WDR62 DTNA PSD3 TAF6L ADAMTS7 TJAP1 PLCE1 | 7.11e-07 | 192 | 277 | 13 | 6513_UP |
| Drug | prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A | ATXN2L INSIG1 GAB2 NCAPD3 TCF3 SH2B1 TRAK1 COL18A1 VPS13D ZNF335 VGLL4 TMCC1 SON | 7.54e-07 | 193 | 277 | 13 | 455_UP |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | ATXN2L PVR MTCL1 WDR62 DLGAP4 PSD3 MED1 OVGP1 TRMT2A CDK13 ZNF335 BCAM PPP6R2 | 7.54e-07 | 193 | 277 | 13 | 5239_DN |
| Drug | Glibenclamide [10238-21-8]; Up 200; 8uM; HL60; HG-U133A | CTIF SEMA3G CHRNA2 TMCC2 SCN5A SCN10A FRAS1 DLGAP4 CRTC1 SH2B1 COL18A1 MISP PRDM14 | 8.98e-07 | 196 | 277 | 13 | 1546_UP |
| Drug | Lynestrenol [52-76-6]; Down 200; 14uM; HL60; HG-U133A | ATG13 GAB2 SUPT5H TCF3 DTNA HIP1R PMEL MLXIP BAHD1 VPS13D N4BP1 CABIN1 HTT | 9.52e-07 | 197 | 277 | 13 | 2037_DN |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | STAT6 NECTIN2 ULK1 WDR62 ZNF821 DTNA PSD3 SH2B1 STC2 PHACTR4 SMPD2 N4BP1 TMCC1 | 1.01e-06 | 198 | 277 | 13 | 6176_DN |
| Drug | Niacin [59-67-6]; Down 200; 32.4uM; MCF7; HT_HG-U133A | BCORL1 NR4A1 IRX4 HPX KMT2A CACNA1H PSD3 MLXIP MED1 BCAM PPP6R2 MUC1 CCDC9 | 1.07e-06 | 199 | 277 | 13 | 3381_DN |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | NR4A1 HPX SCN10A CACNA1H CAMSAP1 WDR62 TCF3 UBXN6 ADAMTS13 COL18A1 CDK13 CABIN1 MUC1 | 1.07e-06 | 199 | 277 | 13 | 2787_UP |
| Drug | Niclosamide [50-65-7]; Up 200; 12.2uM; MCF7; HT_HG-U133A | MAP1B ATG13 INSIG1 PHGDH ULK1 AMOTL2 NCOR2 CDK13 RERE TBR1 ARHGEF2 | 3.93e-06 | 158 | 277 | 11 | 4136_UP |
| Drug | Piroxicam [36322-90-4]; Down 200; 12uM; HL60; HG-U133A | ATG13 PTPRC FAM234B UBXN6 HIP1R VPS13D OVGP1 TRMT2A TJAP1 ARHGEF2 CABIN1 HTT | 4.88e-06 | 194 | 277 | 12 | 1405_DN |
| Drug | Aminopurine, 6-benzyl [1214-39-7]; Down 200; 17.8uM; MCF7; HT_HG-U133A | NR4A1 PVR CACNA1H CEP97 ZIC3 CSF1 CELSR3 MAP1S CDK13 TJAP1 N4BP1 PRDM16 | 5.15e-06 | 195 | 277 | 12 | 2313_DN |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | BCORL1 GAB2 STAT6 NEK1 PVR CAMSAP1 TRAK1 TAF6L CELSR3 MAP1S SMPD2 BCAM | 5.15e-06 | 195 | 277 | 12 | 7451_DN |
| Drug | Phenazopyridine hydrochloride [136-40-3]; Up 200; 16uM; PC3; HT_HG-U133A | INSIG1 ACRV1 PTPRD PVR HPX CAMSAP1 PRUNE2 PRX CSF1 CELSR3 CELSR2 TJAP1 | 5.43e-06 | 196 | 277 | 12 | 5758_UP |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | ATXN2L PVR ALPP DTNA OLFML2B RHOBTB3 NCOR2 CSF1 CELSR3 CDK13 ARHGEF2 MUC1 | 5.43e-06 | 196 | 277 | 12 | 3716_DN |
| Drug | Iopromide [73334-07-3]; Up 200; 5uM; PC3; HT_HG-U133A | CHRNA2 STAT6 WDR62 FAM234B TCF3 OLFML2B MLXIP TAF6L NCOR2 VPS13D TRMT2A TBR1 | 5.72e-06 | 197 | 277 | 12 | 4504_UP |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; MCF7; HT_HG-U133A | PVR SCN10A CHRNA10 PRUNE2 PCBP3 CRTC1 ADAMTS13 TRAK1 NCOR2 HEY2 N4BP1 CABIN1 | 5.72e-06 | 197 | 277 | 12 | 2761_UP |
| Drug | Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A | CTIF CHRNA2 HPX CAMSAP1 CDON TCF3 PSD3 CRTC1 PMEL TRAK1 CSF1 CDK13 | 5.72e-06 | 197 | 277 | 12 | 3399_DN |
| Drug | Alprostadil [745-65-3]; Up 200; 11.2uM; MCF7; HT_HG-U133A | ATXN2L HECW1 PVR CACNA1H WDR62 PRUNE2 UBXN6 TRAK1 TAF6L NCOR2 VPS13D MAP1S | 5.72e-06 | 197 | 277 | 12 | 7358_UP |
| Drug | (+/-)-thalidomide; Up 200; 100uM; MCF7; HG-U133A | FRS2 TSC2 CTIF ZNF821 UBXN6 MED1 TRAK1 ZNF557 VAC14 TRMT2A MEPCE N4BP1 | 6.02e-06 | 198 | 277 | 12 | 266_UP |
| Drug | Glafenine hydrochloride [65513-72-6]; Up 200; 9.8uM; MCF7; HT_HG-U133A | ATP7B ATG13 ACRV1 NEK1 TMCC2 DTNA DLGAP4 TACC2 VPS13D MAP1S CEP72 SMPD2 | 6.02e-06 | 198 | 277 | 12 | 7018_UP |
| Drug | Benoxinate hydrochloride [5987-82-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | ACRV1 BCORL1 NR4A1 PVR CACNA1H WDR62 PCBP3 CRTC1 TRAK1 HEY2 TJAP1 PPP6R2 | 6.02e-06 | 198 | 277 | 12 | 1476_UP |
| Drug | Ampicillin trihydrate [7177-48-2]; Up 200; 10uM; PC3; HT_HG-U133A | WDR62 ZNF821 DTNA OLFML2B CRTC1 ADAMTS13 VPS13D OVGP1 CELSR3 CDK13 N4BP1 ARHGEF2 | 6.34e-06 | 199 | 277 | 12 | 6307_UP |
| Drug | Verapamyl hydrochloride [152-11-4]; Up 200; 8.2uM; MCF7; HT_HG-U133A | NR4A1 STAT6 HPX CACNA1H CDON AKAP6 FRAS1 DLGAP4 ADAMTS13 CSF1 RERE BCAM | 6.34e-06 | 199 | 277 | 12 | 1509_UP |
| Drug | Clioquinol [130-26-7]; Up 200; 13uM; MCF7; HT_HG-U133A | HECW1 CHRNA2 PTPRD PVR SCN10A CAMSAP1 AKAP6 CSF1 CDK13 TJAP1 PRDM14 | 1.95e-05 | 187 | 277 | 11 | 5258_UP |
| Drug | thapsigargin; Down 200; 0.1uM; MCF7; HT_HG-U133A | BCORL1 STAT6 TBC1D4 NECTIN2 TCF3 DTNA TRAK1 COL18A1 MISP CDK13 BCAM | 2.37e-05 | 191 | 277 | 11 | 7100_DN |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | NR4A1 TMCC2 PVR KMT2A CDON DTNA ADAMTS13 SH2B1 ARHGEF2 CABIN1 PPP6R2 | 2.49e-05 | 192 | 277 | 11 | 3929_DN |
| Drug | Ergocryptine-alpha [511-09-1]; Up 200; 7uM; HL60; HT_HG-U133A | ACRV1 SEPTIN8 TMCC2 NECTIN2 SCN5A ZNF821 LAIR2 HIP1R MISP VPS13D TJAP1 | 2.49e-05 | 192 | 277 | 11 | 2572_UP |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | INSIG1 PTPRD SCN10A PRUNE2 ZNF821 TAF6L CSF1 HEY2 BCAM CABIN1 SEC14L5 | 2.61e-05 | 193 | 277 | 11 | 5273_UP |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | INSIG1 ACRV1 CTIF CHRNA2 KMT2A CAMSAP1 CDON HEY2 CABIN1 PPP6R2 MAF | 2.61e-05 | 193 | 277 | 11 | 3296_UP |
| Drug | 5211181; Up 200; 12uM; MCF7; HT_HG-U133A_EA | SPAG4 MAP1B FRS2 TBC1D4 MAP3K9 ZNF821 DLGAP4 PSD3 EFNA4 CEP72 PSD4 | 2.61e-05 | 193 | 277 | 11 | 950_UP |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | ACRV1 FRS2 STAT6 SCN10A KMT2A WDR62 CDON FAM234B DTNA TAF6L CDK13 | 2.87e-05 | 195 | 277 | 11 | 4549_UP |
| Drug | Methazolamide [554-57-4]; Up 200; 17uM; MCF7; HT_HG-U133A | SPAG4 ACRV1 DAG1 KMT2A DLGAP4 CSF1 MAP1S SMPD2 ARHGEF2 CABIN1 TMCC1 | 2.87e-05 | 195 | 277 | 11 | 6268_UP |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | SCN10A FAM234B DLGAP4 UBXN6 PMEL PRDM4 CCDC88C VAC14 VPS13D OVGP1 HTT | 3.01e-05 | 196 | 277 | 11 | 2044_DN |
| Drug | pentamidine isethionate salt; Up 200; 100uM; MCF7; HG-U133A | ZNF142 NR4A1 TBC1D4 PVR KMT2A CACNA1H AMOTL2 VAC14 VPS13D PPP6R2 SEC14L5 | 3.01e-05 | 196 | 277 | 11 | 639_UP |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 3.01e-05 | 196 | 277 | 11 | 5409_DN | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | INSIG1 DAG1 CASZ1 PVR CDON ZNF821 TRAK1 CSF1 TJAP1 BCAM CABIN1 | 3.01e-05 | 196 | 277 | 11 | 4590_DN |
| Drug | Lobeline alpha (-) hydrochoride [134-63-4]; Up 200; 10.6uM; HL60; HG-U133A | CTIF CHRNA2 TMCC2 SCN5A SCN10A AKAP6 CRTC1 VPS13D MAP1S ADAMTS7 PRDM14 | 3.01e-05 | 196 | 277 | 11 | 1770_UP |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; HL60; HT_HG-U133A | SPAG4 ZNF142 MAP1B TBC1D4 NECTIN2 CAMSAP1 WDR62 DTNA OVGP1 EFNA4 MUC1 | 3.15e-05 | 197 | 277 | 11 | 2452_DN |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | MAP1B NR4A1 TBC1D4 PVR PRUNE2 DTNA SH2B1 CELSR3 STC2 MUC1 PSD4 | 3.15e-05 | 197 | 277 | 11 | 6167_DN |
| Drug | FK-506; Up 200; 1uM; MCF7; HG-U133A | ATG13 AP1AR PVR CACNA1H TCF3 PRDM4 TRAK1 TRMT2A SMPD2 N4BP1 CABIN1 | 3.15e-05 | 197 | 277 | 11 | 284_UP |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; MCF7; HT_HG-U133A | ATXN2L MAP1B FRS2 CAMSAP1 WDR62 TRAK1 CCDC88C MAP1S SMPD2 N4BP1 MUC1 | 3.15e-05 | 197 | 277 | 11 | 3235_DN |
| Drug | Xamoterol hemifumarate [73210-73-8]; Down 200; 5uM; MCF7; HT_HG-U133A | CHRNA2 HPX SCN10A WDR62 LAIR2 CRTC1 MLXIP SH2B1 NCOR2 RERE BCAM | 3.15e-05 | 197 | 277 | 11 | 3401_DN |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | FRS2 NEK1 DLGAP4 PMEL TRAK1 ZIC3 TJAP1 RERE ARHGEF2 PRDM16 PSD4 | 3.15e-05 | 197 | 277 | 11 | 2328_DN |
| Drug | trifluoperazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | ZNF142 PVR WDR62 PSD3 MLXIP TAF6L TRMT2A ZNF335 PHACTR4 CABIN1 PPP6R2 | 3.15e-05 | 197 | 277 | 11 | 6984_DN |
| Drug | Prednisone [53-03-2]; Down 200; 11.2uM; PC3; HT_HG-U133A | ATG13 ACRV1 CASZ1 PVR WDR62 CDON TCF3 CRTC1 TAF6L OVGP1 BCAM | 3.15e-05 | 197 | 277 | 11 | 4577_DN |
| Drug | Chelidonine monohydrate (+) [476-32-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | HECW1 ACRV1 PVR SCN10A WDR62 AKAP6 DLGAP4 NCOR2 MAP1S TJAP1 TBR1 | 3.15e-05 | 197 | 277 | 11 | 2779_UP |
| Drug | Salsolinol hydrobromide [38221-21-5]; Up 200; 15.4uM; MCF7; HT_HG-U133A | ATXN2L HECW1 ACRV1 TMCC2 SCN10A CHRNA10 AKAP6 PSD3 N4BP1 RERE HTT | 3.30e-05 | 198 | 277 | 11 | 4816_UP |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | NR4A1 CACNA1H WDR62 AKAP6 TCF3 CRTC1 MED1 ZIC3 MAP1S SMPD2 MUC1 | 3.30e-05 | 198 | 277 | 11 | 4782_UP |
| Drug | Levocabastine hydrochloride [79547-78-7]; Up 200; 8.8uM; MCF7; HT_HG-U133A | CTIF NR4A1 TMCC2 CACNA1H ADAMTSL4 DTNA LAIR2 CRTC1 HEY2 ARHGEF2 PRDM16 | 3.30e-05 | 198 | 277 | 11 | 3509_UP |
| Drug | Novobiocin sodium salt [1476-53-5]; Up 200; 6.4uM; MCF7; HT_HG-U133A | ACRV1 BCORL1 CHRNA2 TMCC2 SCN5A CCDC33 ADAMTS13 BAHD1 CSF1 HEY2 RERE | 3.30e-05 | 198 | 277 | 11 | 4392_UP |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | ZNF142 CTIF CHRNA2 CACNB4 LAIR2 PSD3 PRX TAF6L CDK13 SMPD2 PPP6R2 | 3.30e-05 | 198 | 277 | 11 | 5644_UP |
| Drug | 0179445-0000 [211246-22-9]; Up 200; 1uM; PC3; HT_HG-U133A | HECW1 ACRV1 NR4A1 CASZ1 SCN5A KMT2A DTNA CRTC1 CEMP1 TBR1 PRDM14 | 3.30e-05 | 198 | 277 | 11 | 4292_UP |
| Drug | Paroxetine maleate [64006-44-6]; Up 200; 1uM; MCF7; HT_HG-U133A | CTIF PRDM10 SCN5A HPX CACNA1H DTNA OLFML2B HIP1R CEMP1 CDK13 PRDM16 | 3.30e-05 | 198 | 277 | 11 | 4378_UP |
| Drug | Progesterone [57-83-0]; Up 200; 12.8uM; MCF7; HT_HG-U133A | ATXN2L CTIF NR4A1 ULK1 MLXIP TRAK1 NCOR2 VPS13D CSF1 HEY2 MAF | 3.46e-05 | 199 | 277 | 11 | 3287_UP |
| Drug | estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A | TSC2 PSD3 MLXIP BAHD1 TRAK1 VAC14 TRMT2A ZNF335 SMPD2 PPP6R2 MUC1 | 3.46e-05 | 199 | 277 | 11 | 6968_DN |
| Drug | DAPH; Up 200; 10uM; PC3; HG-U133A | ATXN2L ZNF142 HECW1 STAT6 TBC1D4 WDR62 SH2B1 OVGP1 CSF1 CELSR2 PLPBP | 3.46e-05 | 199 | 277 | 11 | 578_UP |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | EYA2 STAT6 TCF3 PSD3 TRAK1 CEP72 BCAM CABIN1 PPP6R2 MUC1 CCDC9 | 3.46e-05 | 199 | 277 | 11 | 5575_DN |
| Drug | LY 294002; Down 200; 0.1uM; HL60; HT_HG-U133A | ZNF142 PVR CDON TCF3 RHOBTB3 NCOR2 OVGP1 CELSR2 SMPD2 MUC1 MAF | 3.46e-05 | 199 | 277 | 11 | 2676_DN |
| Drug | Atropine-N-oxide hydrochloride [4574-60-1]; Down 200; 11.8uM; MCF7; HT_HG-U133A | ATXN2L TMCC2 HPX CACNA1H CAMSAP1 CDON CRTC1 SH2B1 TRAK1 OVGP1 ARHGEF2 | 3.46e-05 | 199 | 277 | 11 | 2216_DN |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | FRS2 DAG1 NEK1 PSD3 MED1 VPS13D ZNF335 BCAM CABIN1 PPP6R2 PSD4 | 3.46e-05 | 199 | 277 | 11 | 7000_DN |
| Drug | Probenecid [57-66-9]; Up 200; 14uM; HL60; HT_HG-U133A | ATP7B HECW1 TMCC2 SCN5A HPX SCN10A OLFML2B HIP1R ADAMTS7 N4BP1 MUC1 | 3.46e-05 | 199 | 277 | 11 | 2464_UP |
| Drug | arachidonic acid sodium salt; Down 200; 10uM; MCF7; HG-U133A | ATXN2L NR4A1 IL22RA1 GAB2 PVR HPX ZNF821 OLFML2B CRTC1 VAC14 SMPD2 | 3.62e-05 | 200 | 277 | 11 | 604_DN |
| Drug | Dimaprit dihydrochloride [23256-33-9]; Up 200; 17uM; MCF7; HT_HG-U133A | MAP1B IL22RA1 MAP3K9 ULK1 CEP97 CRTC1 TRAK1 VPS13D OVGP1 CDK13 TJAP1 | 3.62e-05 | 200 | 277 | 11 | 7480_UP |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 4.08e-05 | 104 | 277 | 8 | ctd:C000595015 | |
| Drug | pyrvinium pamoate; Up 200; 1.25uM; MCF7; HT_HG-U133A_EA | MAP1B INSIG1 CDHR5 NR4A1 ULK1 AMOTL2 WDR62 KMT2D TJAP1 ARHGEF2 | 6.53e-05 | 177 | 277 | 10 | 870_UP |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | ATXN2L MAP1B INSIG1 DAG1 CACNA1H ZNF821 UBXN6 CABIN1 CCDC9 MAF | 7.51e-05 | 180 | 277 | 10 | 7356_UP |
| Drug | valinomycin; Up 200; 0.1uM; MCF7; HT_HG-U133A | 9.02e-05 | 184 | 277 | 10 | 5957_UP | |
| Drug | Methotrexate [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A | 1.13e-04 | 189 | 277 | 10 | 2041_DN | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; HL60; HT_HG-U133A | CHRNA2 SEPTIN8 TMCC2 KMT2A CAMSAP1 TCF3 OVGP1 CEP72 N4BP1 TMCC1 | 1.18e-04 | 190 | 277 | 10 | 2143_UP |
| Drug | Rapamycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.23e-04 | 191 | 277 | 10 | 5581_DN | |
| Drug | 11-deoxy-16,16-dimethyl Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 1.23e-04 | 191 | 277 | 10 | 7538_UP | |
| Drug | Metixene hydrochloride [1553-34-0]; Up 200; 11.6uM; MCF7; HT_HG-U133A | INSIG1 BCORL1 CTIF CEP97 CDON COL16A1 NCOR2 VPS13D OVGP1 SEC14L5 | 1.28e-04 | 192 | 277 | 10 | 3313_UP |
| Drug | Dipyridamole [58-32-2]; Down 200; 8uM; MCF7; HT_HG-U133A | INSIG1 TBC1D4 TCF3 DTNA PSD3 CCDC88C VPS13D PHACTR4 SMPD2 SON | 1.28e-04 | 192 | 277 | 10 | 1517_DN |
| Drug | Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A | BCORL1 HPX MTCL1 CAMSAP1 LAIR2 VPS13D TRMT2A RERE BCAM CCDC9 | 1.34e-04 | 193 | 277 | 10 | 3378_DN |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 6833_DN | |
| Drug | Zalcitabine [7481-89-2]; Up 200; 19uM; MCF7; HT_HG-U133A | ATXN2L NECTIN2 SCN10A MAP3K9 CACNA1H CAMSAP1 PSD3 PMEL VPS13D CABIN1 | 1.40e-04 | 194 | 277 | 10 | 7352_UP |
| Drug | Gallamine triethiodide [65-29-2]; Down 200; 4.4uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 2221_DN | |
| Drug | Acetylsalicylsalicylic acid [530-75-6]; Down 200; 13.4uM; HL60; HG-U133A | ACRV1 BCORL1 NR4A1 CHRNA2 CASZ1 GAB2 NECTIN2 TCF3 DLGAP4 OVGP1 | 1.40e-04 | 194 | 277 | 10 | 1377_DN |
| Drug | Iopromide [73334-07-3]; Down 200; 5uM; HL60; HT_HG-U133A | ATXN2L CAMSAP1 CEP97 ZNF821 HIP1R VPS13D EFNA4 CSF1 ZNF335 TMCC1 | 1.40e-04 | 194 | 277 | 10 | 2739_DN |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 3855_UP | |
| Drug | splitomicin; Up 200; 20uM; PC3; HG-U133A | 1.40e-04 | 194 | 277 | 10 | 661_UP | |
| Drug | Sulfaquinoxaline sodium salt [967-80-6]; Down 200; 12.4uM; MCF7; HT_HG-U133A | BCORL1 FRS2 NR4A1 NEK1 PVR DLGAP4 UBXN6 TRAK1 ARHGEF2 CABIN1 | 1.40e-04 | 194 | 277 | 10 | 6090_DN |
| Drug | Pindolol [13523-86-9]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 1.40e-04 | 194 | 277 | 10 | 2238_DN | |
| Drug | clofibrate; Up 200; 150uM; MCF7; HG-U133A | 1.40e-04 | 194 | 277 | 10 | 263_UP | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | TMCC2 PVR CACNA1H CEP97 WDR62 CDON ZNF821 BAHD1 CSF1 ARHGEF2 | 1.46e-04 | 195 | 277 | 10 | 6035_DN |
| Drug | rapamycin, Streptomyces hygroscepicus; Down 200; 0.1uM; PC3; HT_HG-U133A | NR4A1 PVR FAM234B DTNA DLGAP4 TAF6L TRMT2A ADAMTS7 STC2 N4BP1 | 1.46e-04 | 195 | 277 | 10 | 5980_DN |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | ATXN2L CASZ1 PHGDH ALPP FAM234B RHOBTB3 NCOR2 CDK13 N4BP1 BCAM | 1.46e-04 | 195 | 277 | 10 | 3715_DN |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 3844_UP | |
| Drug | Delcorine; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 3613_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | HECW1 ZNF423 ACRV1 CTIF SCN10A PRUNE2 ADAMTS13 PMEL SNX29 PRX | 1.46e-04 | 195 | 277 | 10 | 5576_UP |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | ATXN2L INSIG1 KMT2A CACNA1H TCF3 DTNA NCOR2 OVGP1 PRDM14 PSD4 | 1.46e-04 | 195 | 277 | 10 | 207_UP |
| Drug | Nitrarine dihydrochloride [20069-05-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A | DAG1 CHRNA2 SCN10A CAMSAP1 TCF3 BAHD1 CEMP1 CSF1 CDK13 TJAP1 | 1.46e-04 | 195 | 277 | 10 | 4705_UP |
| Drug | Ticlopidine hydrochloride [53885-35-1]; Down 200; 13.4uM; MCF7; HT_HG-U133A | ATG13 SEMA3G TMCC2 SCN10A TCF3 DLGAP4 CRTC1 TRAK1 VPS13D PPP6R2 | 1.46e-04 | 195 | 277 | 10 | 4155_DN |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 1.46e-04 | 195 | 277 | 10 | 2707_DN | |
| Drug | Oxamniquine [21738-42-1]; Up 200; 14.4uM; MCF7; HT_HG-U133A | ATXN2L CHRNA2 CHRNA10 WDR62 CDON DLGAP4 HIP1R SH2B1 NCOR2 RERE | 1.46e-04 | 195 | 277 | 10 | 4124_UP |
| Disease | electrocardiography | ATXN2L MYCBP2 CASZ1 IRX4 CDC123 SCN5A SCN10A KCNN3 OLFML2B JSRP1 TRAK1 SH3PXD2B SPATS2L HEY2 FOXP1 MUC1 PRDM16 PLCE1 | 2.24e-06 | 530 | 270 | 18 | EFO_0004327 |
| Disease | Brugada ECG Pattern | 3.01e-06 | 4 | 270 | 3 | C1721096 | |
| Disease | mean platelet volume | TEX2 KIAA0232 CYP21A2 BCORL1 TOX4 TBC1D4 PTPRC PTPRJ TMCC2 PVR NECTIN2 FBXO34 FGD3 TCF12 PCDHGB6 PCDHGA7 PCDHGA3 PSD3 HIP1R CRTC1 PRDM16 PCDHGC3 SEC14L5 HTT PLCE1 | 8.72e-06 | 1020 | 270 | 25 | EFO_0004584 |
| Disease | Alzheimer disease, polygenic risk score | ATP7B ATG13 PVR NECTIN2 CCDC33 CACNA1E FRAS1 TCF20 PCDHGA3 PSD3 HIP1R TACC2 VAC14 CEACAM16 ROBO1 BCAM MUC1 MAF | 8.90e-06 | 586 | 270 | 18 | EFO_0030082, MONDO_0004975 |
| Disease | lymphocyte count | PHF19 KIAA0232 CYP21A2 LDLRAD3 ZNF831 CASZ1 GAB2 TYK2 TOX4 PTPRC PTPRJ PVR NECTIN2 VARS1 FRAS1 PCDHGB6 PCDHGA7 PCDHGA3 ICAM3 HECTD4 PSD3 GPRIN3 CSF1 CDK13 FOXP1 DMRTA1 RERE PCDHGC3 HTT PLCE1 PSD4 | 1.33e-05 | 1464 | 270 | 31 | EFO_0004587 |
| Disease | balding measurement | DENND2A PDE3A MYCBP2 ZNF423 CTIF CASZ1 PTPRC SDC1 CDON TBX15 TCF12 CRTC1 REV3L PRDM4 NCOR2 SH3PXD2B FOXP1 VGLL4 RERE GLIS1 MAF | 1.49e-05 | 792 | 270 | 21 | EFO_0007825 |
| Disease | Malignant neoplasm of breast | XIRP1 ATP7B BCORL1 CTIF NDUFA8 PHGDH FASN NOP9 PTPRC PTPRD NECTIN2 AKAP6 ZNF438 PCDHGB6 ZSWIM5 TACC2 EPG5 KMT2D FXR1 CSF1 TRMT2A STC2 HEY2 ROBO1 | 5.78e-05 | 1074 | 270 | 24 | C0006142 |
| Disease | waist-hip ratio | MYCBP2 ZNF423 DAG1 EYA2 MEFV HAUS8 CCM2 PTPRD KCNN3 CDON TBX15 PRUNE2 SEC16B HECTD4 HIP1R CRTC1 SH2B1 COL18A1 SH3PXD2B STC2 ROBO1 RERE MUC1 PRDM16 HTT PLCE1 | 6.69e-05 | 1226 | 270 | 26 | EFO_0004343 |
| Disease | mental development measurement | 7.45e-05 | 25 | 270 | 4 | EFO_0008230 | |
| Disease | OROFACIAL CLEFT 1 | 8.34e-05 | 2 | 270 | 2 | C1861537 | |
| Disease | cerebral palsy (implicated_via_orthology) | 8.67e-05 | 10 | 270 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | prostate cancer (is_marker_for) | 1.00e-04 | 156 | 270 | 8 | DOID:10283 (is_marker_for) | |
| Disease | QT interval | ATXN2L PDE3A KIAA0232 CASZ1 PTPRJ SCN5A SCN10A FRAS1 OLFML2B SH2B1 TRAK1 SPATS2L CDK13 HEY2 FOXP1 | 1.35e-04 | 534 | 270 | 15 | EFO_0004682 |
| Disease | hypertension | PDE3A ZNF423 ZNF831 CASZ1 PTPRJ HECTD4 KCP RNF213 NCOR2 PRDM16 PLCE1 | 1.35e-04 | 307 | 270 | 11 | EFO_0000537 |
| Disease | cup-to-disc ratio measurement | EYA2 CCM2 KMT2A MTCL1 AMOTL2 FRAS1 PRDM4 SYNE3 CSF1 FOXP1 RERE PRDM16 PLCE1 | 1.85e-04 | 430 | 270 | 13 | EFO_0006939 |
| Disease | vital capacity | ATXN2L DENND2A PDE3A CTIF EYA2 CASZ1 PTPRD CDC123 MTCL1 TBX15 ZNF438 TCF20 PCDHAC1 GPRIN3 CLIC6 MED1 SH2B1 KCNH3 NCOR2 FOXP1 DMRTA1 PPP6R2 MUC1 PLCE1 MAF | 1.92e-04 | 1236 | 270 | 25 | EFO_0004312 |
| Disease | Brugada Syndrome 1 | 2.02e-04 | 13 | 270 | 3 | C4551804 | |
| Disease | platelet component distribution width | DENND2A KIAA0232 CYP21A2 ZNF831 GAB2 SEPTIN8 TOX4 PTPRC TMCC2 PVR PIF1 FGD3 PRUNE2 COL18A1 NCOR2 PRDM16 SEC14L5 MAF | 2.29e-04 | 755 | 270 | 18 | EFO_0007984 |
| Disease | response to thiazide, low density lipoprotein cholesterol measurement | 2.49e-04 | 3 | 270 | 2 | EFO_0004611, EFO_0007981 | |
| Disease | alcoholic liver cirrhosis, alcoholic pancreatitis, alcohol dependence | 2.49e-04 | 3 | 270 | 2 | EFO_1000802, EFO_1002013, MONDO_0007079 | |
| Disease | response to anti-tuberculosis drug, drug-induced liver injury | 2.49e-04 | 3 | 270 | 2 | EFO_0004228, EFO_0007918 | |
| Disease | four-jointed box protein 1 measurement | 2.49e-04 | 3 | 270 | 2 | EFO_0801605 | |
| Disease | Pitt-Hopkins syndrome (implicated_via_orthology) | 2.49e-04 | 3 | 270 | 2 | DOID:0060488 (implicated_via_orthology) | |
| Disease | T wave morphology measurement | 2.56e-04 | 14 | 270 | 3 | EFO_0008398 | |
| Disease | neuroimaging measurement | ATXN2L SPIRE2 MAP1B CYP21A2 NDUFA8 TYK2 CCM2 ZNF438 TACC2 REV3L CCDC88C NHSL1 COL18A1 HEY2 ROBO1 FOXP1 DMRTA1 RERE PRDM16 HTT PLCE1 MAF | 3.71e-04 | 1069 | 270 | 22 | EFO_0004346 |
| Disease | diabetes mellitus | 4.03e-04 | 68 | 270 | 5 | EFO_0000400 | |
| Disease | immature platelet count | 4.41e-04 | 106 | 270 | 6 | EFO_0803544 | |
| Disease | migraine disorder | CTIF CASZ1 PTPRD SCN10A RNF213 POU4F3 REV3L NCOR2 FOXP1 PRDM16 PLCE1 | 4.90e-04 | 357 | 270 | 11 | MONDO_0005277 |
| Disease | childhood trauma measurement, alcohol consumption measurement | 4.92e-04 | 71 | 270 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | corneal topography | 5.12e-04 | 109 | 270 | 6 | EFO_0004345 | |
| Disease | low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 5.41e-04 | 153 | 270 | 7 | EFO_0004611, EFO_0020946 | |
| Disease | esophageal adenocarcinoma | 5.58e-04 | 18 | 270 | 3 | EFO_0000478 | |
| Disease | mean corpuscular hemoglobin concentration | ATP7B CYP21A2 DAG1 TSC2 MEFV PHGDH HAUS8 TBC1D4 PTPRC TMCC2 NECTIN2 MAPK8IP1 DLGAP4 HECTD4 PSD3 SH2B1 NCAN FOXP1 DMRTA1 AGAP7P PRDM16 BORA | 5.77e-04 | 1105 | 270 | 22 | EFO_0004528 |
| Disease | familial atrial fibrillation | 6.08e-04 | 156 | 270 | 7 | C3468561 | |
| Disease | Persistent atrial fibrillation | 6.08e-04 | 156 | 270 | 7 | C2585653 | |
| Disease | Paroxysmal atrial fibrillation | 6.08e-04 | 156 | 270 | 7 | C0235480 | |
| Disease | body weight | ATXN2L ZNF423 CYP21A2 EYA2 FASN TOX4 MEX3A PTPRJ CDC123 FRRS1L AKAP6 SEC16B COL16A1 HECTD4 CRTC1 PRDM4 SH2B1 SH3PXD2B HEY2 DMRTA1 VGLL4 ADAMTS14 MUC1 CDH7 | 6.16e-04 | 1261 | 270 | 24 | EFO_0004338 |
| Disease | Brugada syndrome | 6.59e-04 | 19 | 270 | 3 | MONDO_0015263 | |
| Disease | Atrial Fibrillation | 7.06e-04 | 160 | 270 | 7 | C0004238 | |
| Disease | aspartate aminotransferase measurement | PDE3A EYA2 NDUFA8 GAB2 PANK2 PTPRC PTPRD PTPRJ TMCC2 VARS1 HECTD4 RNF213 GPRIN3 NCOR2 CSF1 TMEM132D ROBO1 DMRTA1 PLCE1 | 7.23e-04 | 904 | 270 | 19 | EFO_0004736 |
| Disease | phospholipid measurement, high density lipoprotein cholesterol measurement | PDE3A CYP21A2 NECTIN2 PSD3 SNX29 NCOR2 CSF1 CELSR2 NCAN BCAM | 8.07e-04 | 321 | 270 | 10 | EFO_0004612, EFO_0004639 |
| Disease | hypertension, pregnancy-induced | 8.19e-04 | 5 | 270 | 2 | MONDO_0024664 | |
| Disease | response to platinum based chemotherapy, cytotoxicity measurement | 8.19e-04 | 5 | 270 | 2 | EFO_0004647, EFO_0006952 | |
| Disease | DiGeorge syndrome (is_implicated_in) | 8.19e-04 | 5 | 270 | 2 | DOID:11198 (is_implicated_in) | |
| Disease | Chromosome 1p36 Deletion Syndrome | 8.19e-04 | 5 | 270 | 2 | C1842870 | |
| Disease | serum gamma-glutamyl transferase measurement | UBR1 CYP21A2 NECTIN2 KCNN3 KMT2A ULK1 SEC16B ZSWIM5 HECTD4 PSD3 NCOR2 SH3PXD2B CELSR2 MAP1S ROBO1 ARHGEF2 CABIN1 PPP6R2 PLCE1 | 8.24e-04 | 914 | 270 | 19 | EFO_0004532 |
| Disease | Precursor B-cell lymphoblastic leukemia | 8.92e-04 | 21 | 270 | 3 | C1292769 | |
| Disease | stroke, coronary artery disease | 8.92e-04 | 21 | 270 | 3 | EFO_0000712, EFO_0001645 | |
| Disease | Intellectual Disability | ZNF142 MAP1B PRR12 FASN WDR62 AKAP6 CACNA1E TCF20 PITRM1 COL18A1 ZNF335 HTT | 9.26e-04 | 447 | 270 | 12 | C3714756 |
| Disease | longitudinal BMI measurement | 9.50e-04 | 82 | 270 | 5 | EFO_0005937 | |
| Disease | lipid measurement, high density lipoprotein cholesterol measurement | PDE3A CYP21A2 NECTIN2 PSD3 SNX29 NCOR2 CSF1 CELSR2 NCAN BCAM | 9.94e-04 | 330 | 270 | 10 | EFO_0004529, EFO_0004612 |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 1.06e-03 | 222 | 270 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | pulse pressure measurement | PDE3A PHF19 MAP1B TEX2 ZNF423 ZNF831 CASZ1 FASN PTPRD CDC123 SCN10A CEP97 PIF1 CREB3L2 ZNF438 PCBP3 DLGAP4 PCDHAC1 RNF213 TRAK1 VAC14 PHACTR4 FOXP1 PRDM16 PLCE1 | 1.08e-03 | 1392 | 270 | 25 | EFO_0005763 |
| Disease | myeloid white cell count | PDE3A PHF19 ZNF423 CYP21A2 CTIF PTPRC PTPRJ SUPT5H FBXO34 TBX15 PRUNE2 HECTD4 PRX CSF1 FOXP1 DMRTA1 RERE HTT PLCE1 | 1.10e-03 | 937 | 270 | 19 | EFO_0007988 |
| Disease | cholesteryl ester measurement, very low density lipoprotein cholesterol measurement | 1.16e-03 | 225 | 270 | 8 | EFO_0008317, EFO_0010351 | |
| Disease | insulin sensitivity measurement | 1.17e-03 | 23 | 270 | 3 | EFO_0004471 | |
| Disease | liposarcoma | 1.22e-03 | 6 | 270 | 2 | C0023827 | |
| Disease | Epilepsy, Generalized | 1.22e-03 | 6 | 270 | 2 | C0014548 | |
| Disease | Idiopathic generalized epilepsy | 1.22e-03 | 6 | 270 | 2 | cv:C0270850 | |
| Disease | cholesterol to total lipids in small HDL percentage | 1.22e-03 | 51 | 270 | 4 | EFO_0022240 | |
| Disease | Alzheimer disease, gastroesophageal reflux disease | 1.26e-03 | 228 | 270 | 8 | EFO_0003948, MONDO_0004975 | |
| Disease | apolipoprotein B measurement | CASZ1 PVR NECTIN2 ZNF821 TCF12 PSD3 HAVCR2 CELSR2 NCAN KANK4 BCAM PPP6R2 MUC1 HTT MAF | 1.27e-03 | 663 | 270 | 15 | EFO_0004615 |
| Disease | Brugada Syndrome (disorder) | 1.33e-03 | 24 | 270 | 3 | C1142166 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 1.41e-03 | 53 | 270 | 4 | EFO_0022286 | |
| Disease | migraine disorder, diastolic blood pressure | 1.50e-03 | 25 | 270 | 3 | EFO_0006336, MONDO_0005277 | |
| Disease | sleep duration, low density lipoprotein cholesterol measurement | 1.51e-03 | 91 | 270 | 5 | EFO_0004611, EFO_0005271 | |
| Disease | Ischemic stroke, fibrinogen measurement | 1.62e-03 | 55 | 270 | 4 | EFO_0004623, HP_0002140 | |
| Disease | asthma | EYA2 LDLRAD3 STAT6 SEPTIN8 HAUS8 FBLN2 PTPRC FLG COL16A1 MUC16 PMEL MED1 TMEM132D FOXP1 RERE PRDM16 | 1.64e-03 | 751 | 270 | 16 | MONDO_0004979 |
| Disease | L lactate dehydrogenase measurement | 1.69e-03 | 26 | 270 | 3 | EFO_0004808 | |
| Disease | Alzheimer disease, high density lipoprotein cholesterol measurement | 1.69e-03 | 26 | 270 | 3 | EFO_0004612, MONDO_0004975 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 1.69e-03 | 239 | 270 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | electrocardiography, PR interval | 1.70e-03 | 7 | 270 | 2 | EFO_0004327, EFO_0004462 | |
| Disease | myoclonic-atonic epilepsy (implicated_via_orthology) | 1.70e-03 | 7 | 270 | 2 | DOID:0060475 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.70e-03 | 7 | 270 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Pituitary stalk interruption syndrome | 1.70e-03 | 7 | 270 | 2 | C4053775 | |
| Disease | QRS duration | 1.80e-03 | 298 | 270 | 9 | EFO_0005055 | |
| Disease | platelet-to-lymphocyte ratio | CYP21A2 ZNF831 PHGDH TYK2 PTPRC PTPRJ TMCC2 VARS1 ICAM3 FOXP1 | 2.01e-03 | 363 | 270 | 10 | EFO_0008446 |
| Disease | neuroblastoma, cutaneous melanoma | 2.10e-03 | 28 | 270 | 3 | EFO_0000389, EFO_0000621 | |
| Disease | triglycerides to total lipids in small LDL percentage | 2.10e-03 | 59 | 270 | 4 | EFO_0022337 | |
| Disease | JT interval | 2.13e-03 | 248 | 270 | 8 | EFO_0007885 | |
| Disease | melanoma | 2.13e-03 | 248 | 270 | 8 | C0025202 | |
| Disease | PR interval | PDE3A MYCBP2 DAG1 SRGAP1 SCN5A SCN10A AKAP6 DTNA TRAK1 SYNE3 TJAP1 FOXP1 | 2.18e-03 | 495 | 270 | 12 | EFO_0004462 |
| Disease | alcohol-related neurodevelopmental disorder (implicated_via_orthology) | 2.25e-03 | 8 | 270 | 2 | DOID:0050667 (implicated_via_orthology) | |
| Disease | sporadic amyotrophic lateral sclerosis, survival time | 2.25e-03 | 8 | 270 | 2 | EFO_0000714, EFO_0001357 | |
| Disease | glycosyl-N-(2-hydroxynervonoyl)-sphingosine (d18:1/24:1(2OH)) measurement | 2.25e-03 | 8 | 270 | 2 | EFO_0800533 | |
| Disease | basal cell adhesion molecule measurement | 2.25e-03 | 8 | 270 | 2 | EFO_0008032 | |
| Disease | 1,5 anhydroglucitol measurement | 2.32e-03 | 29 | 270 | 3 | EFO_0008009 | |
| Disease | mean arterial pressure | ZNF423 ZNF831 CASZ1 PTPRD PTPRJ TCF20 HECTD4 RNF213 ROBO1 RERE PRDM16 PLCE1 | 2.32e-03 | 499 | 270 | 12 | EFO_0006340 |
| Disease | metabolic syndrome | 2.54e-03 | 200 | 270 | 7 | EFO_0000195 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 2.61e-03 | 103 | 270 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | free cholesterol measurement, high density lipoprotein cholesterol measurement | 2.62e-03 | 315 | 270 | 9 | EFO_0004612, EFO_0008591 | |
| Disease | platelet measurement | KIAA0232 CYP21A2 GAB2 TMCC2 FBXO34 TCF12 DMRTA1 PRDM16 SEC14L5 | 2.62e-03 | 315 | 270 | 9 | EFO_0005036 |
| Disease | forced expiratory volume | ATXN2L FRS2 CASZ1 CDC123 MTCL1 CDON TSHZ3 PSD3 MED1 SH2B1 NCOR2 SPATS2L CEP72 FOXP1 PPP6R2 MUC1 | 2.67e-03 | 789 | 270 | 16 | EFO_0004314 |
| Disease | triglycerides to total lipids in medium VLDL percentage | 2.67e-03 | 63 | 270 | 4 | EFO_0022335 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus | 2.82e-03 | 31 | 270 | 3 | EFO_0000280, EFO_0000478 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.83e-03 | 152 | 270 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | ATXN2L CYP21A2 PKD1L1 BCORL1 EYA2 CMYA5 GAB2 PTPRJ NECTIN2 SDC1 HECTD4 MLXIP CELSR2 ADAMTS7 NCAN HTT PLCE1 | 2.87e-03 | 869 | 270 | 17 | EFO_0004735 |
| Disease | lung cancer (implicated_via_orthology) | 2.88e-03 | 9 | 270 | 2 | DOID:1324 (implicated_via_orthology) | |
| Disease | Situs ambiguous | 2.88e-03 | 9 | 270 | 2 | C1167664 | |
| Disease | supraventricular ectopy | 2.88e-03 | 9 | 270 | 2 | EFO_0009277 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPGSASTNVVLRHDG | 126 | Q9GZZ6 | |
| PENHADTIGSGRAIP | 246 | Q96P64 | |
| HGSRDGSTQTEGPPD | 721 | Q9Y2J4 | |
| RVPAEGSEGLPESHS | 1371 | Q9HCE0 | |
| SPETESPLQGSLHSD | 416 | O75143 | |
| HSLQTPTEEGQGPEG | 31 | Q6UY14 | |
| DAHLRGPSGIITSPN | 406 | Q7Z408 | |
| AGDTGHSSLEAPRSP | 286 | O43310 | |
| ASQSTEPEIGHLSPS | 221 | Q8N5R6 | |
| IRHAGSISPPADGSE | 2176 | Q15878 | |
| GSHTEGSPSQPRDQE | 51 | Q86V15 | |
| STGAPGPHEASQDRS | 916 | Q86V15 | |
| GTPTSVQEVAPHTGR | 451 | P35670 | |
| HGARDSNVTLAPSGP | 321 | Q07092 | |
| QGPTSKDEAGVSEHP | 946 | Q12774 | |
| GSEEEGSSRLSPPHS | 946 | Q92974 | |
| STGDETPGPAHTGRE | 71 | Q2WEN9 | |
| TPHESQIPGASLGIT | 206 | P00390 | |
| APSATIHQGEEEGPL | 91 | Q9NWN3 | |
| GVPSLSSSEAVHGLP | 871 | Q5H9F3 | |
| SSSEAVHGLPEGQPR | 876 | Q5H9F3 | |
| PTALPQGGSHTETED | 46 | Q15822 | |
| PPISQASEGASSDIH | 121 | Q9H2A7 | |
| PESVDVGGASPHSKT | 271 | Q9BSQ5 | |
| SDEGESPGSSHRPLT | 51 | Q63HQ0 | |
| GVTDTREPSPGSHSA | 396 | Q9P209 | |
| EGSTTEVPEGLQLHP | 481 | Q9UI46 | |
| PEGVNSLDPSHGESI | 1771 | Q9HCU4 | |
| SQEGQDTIRGHPGPS | 2131 | P20930 | |
| RDTPGENVEPSHTAT | 206 | Q9HBB8 | |
| SSPHGEASRGAAEPE | 396 | Q96NY7 | |
| EPESVHSGGTPSQRV | 1411 | Q5T5Y3 | |
| TADGPHSPTSQVARG | 11 | O00305 | |
| HGPIAVLANSSDPST | 1431 | Q14004 | |
| AEAPSSSEPHGARGS | 36 | Q9UER7 | |
| QGTLTSSESHPEAAP | 646 | Q9Y2H0 | |
| GEQPSGEQPSGEHLS | 111 | P26436 | |
| HEEAAAPGRTTATPA | 1141 | Q76LX8 | |
| GEDLRHPGTSLPAAS | 1206 | Q8WXS8 | |
| VGSTHSSPSPDVAEL | 1246 | Q9UKP4 | |
| HLDNSSPGPGSEARG | 386 | Q8WWM7 | |
| PENHADTIGSGRAIP | 246 | Q5VW22 | |
| SSSLNHVPDLEAGPS | 171 | P57052 | |
| DGGDPPRSSTAHIQV | 216 | Q9Y5G6 | |
| AVHSLEEPLPQTSSG | 221 | A6NNM3 | |
| AVHSLEEPLPQTSSG | 221 | A6NJZ7 | |
| ATSPSVALPHSGALD | 411 | P78413 | |
| IGDGLSPLPHLTESS | 896 | Q9Y4B5 | |
| DGGDPPRSATAHIEI | 216 | Q9Y5F9 | |
| GLLTVPHGPSEARNT | 861 | Q9ULD8 | |
| SHESAVTALVPPGSE | 761 | Q9HCM3 | |
| TSPHLEGSGILDTPV | 236 | P22736 | |
| RSVPNLTEGSLHEPG | 961 | Q96NW4 | |
| SEVPPAHGSALLTAT | 216 | Q9UBP5 | |
| STVATLQGTPDHGDP | 156 | Q8IVT2 | |
| GIAHLPIGTSSPAET | 1646 | Q8WXI7 | |
| VEIPSSGHESPSSAL | 7186 | Q8WXI7 | |
| KEDGRSSSGPPHETA | 1291 | Q9Y618 | |
| GDRPPSVSSVHSEGD | 2421 | Q9Y618 | |
| PAGSHVLDAILTSPS | 521 | Q86U38 | |
| AGSPTAPVHDESLVG | 301 | Q12913 | |
| LLSVEDTSHSPGQPG | 311 | Q86YD5 | |
| ADEGQHLPDGRTATP | 1391 | Q86XX4 | |
| SPGREPASSIHDETL | 1076 | P46821 | |
| DAVLVTHPGADSLPG | 286 | Q66K74 | |
| PSPGSGSEQKAHLED | 76 | O75444 | |
| SATPRLADSGSVPHD | 36 | Q96MG2 | |
| GVKSSDVSPPLGQHE | 646 | Q96PY6 | |
| SQGPEGLAPHSAIEE | 871 | Q9HCH0 | |
| TVPPHQEAASGELRG | 31 | Q7L2J0 | |
| GEQDLSRHAGSPPGS | 436 | Q9NVR5 | |
| ESSASSDGLHPVITP | 346 | Q8N307 | |
| TAGRPHPSISEEEEG | 321 | Q9UQF2 | |
| EEHGPSEKAINGPTS | 571 | P51114 | |
| GPHDGVTIPRSTSDT | 56 | Q76N89 | |
| HPSTGSESDSSPRQG | 651 | Q76N89 | |
| THLEEADGGPEPTRN | 26 | Q8N5S9 | |
| PPGDTLVHLGDVLST | 616 | Q9H252 | |
| HGVTSAPDNRPALGS | 936 | P15941 | |
| HSELQSVRTASPDPG | 161 | Q14118 | |
| GGRETGSHTLQSPAP | 1836 | Q9P219 | |
| LDHELGPGASSSRVP | 321 | P08686 | |
| VPSPTTGEEGSVHSR | 1231 | Q5SYE7 | |
| ATSRSTGPEGVTHAP | 346 | P98095 | |
| THFRPISASELSPGG | 1106 | Q92628 | |
| AVGTTHTPISDSPIG | 701 | Q9UGI6 | |
| RGPTILDAPNTEGAH | 176 | Q96B70 | |
| PIPGLSTVINDHGST | 771 | Q14432 | |
| SRGIPSSPGAHTTEA | 171 | P39060 | |
| SSPGAHTTEAGTLPA | 176 | P39060 | |
| DGTSTRAFHPQTGLP | 801 | Q32MH5 | |
| TRTTGPSSEGHPAAL | 561 | A2RU67 | |
| RKSESAHPVGSPGES | 156 | P52798 | |
| SHTPPINGSDSILGT | 311 | Q99081 | |
| GGLERTPFLSPSHSD | 101 | A2RU54 | |
| EGPLSLVTTANHSPD | 646 | Q9H334 | |
| SVSGPSLLAAHGAPD | 41 | O15503 | |
| SIPNDSPARGEGTHS | 61 | Q9NQ92 | |
| KRHEGSSSESVPPGT | 16 | Q6P1K2 | |
| PTETSNGSPGHLDLV | 1526 | P00451 | |
| EAVSGHPQASGSRSP | 336 | O15553 | |
| LEAGPSPTVLGAHAE | 96 | Q5JSP0 | |
| SGGVQVEPPAHSDSL | 1101 | Q9NQV6 | |
| LPPHTVEGTSASLND | 526 | P23471 | |
| GTRFPLESAHDPDVG | 151 | Q9UN70 | |
| IHTSLPATGDGSAPV | 1836 | Q9Y4D8 | |
| DLQSTLLEGHGTAPP | 86 | Q9BT25 | |
| GHTTPIGNARSSSPV | 106 | Q8IZ21 | |
| GLDASPPASTHELTI | 286 | P57721 | |
| GPIVNLSEPTAHEGS | 316 | P32942 | |
| AVLTPHSGSETPRGT | 151 | O43316 | |
| SLHSLSEGDDARPPG | 811 | Q2TAC6 | |
| SPPRHDSLSLDGGTV | 41 | Q9BZ23 | |
| HGDPPLSSSVTLGVL | 641 | Q9H158 | |
| DGGSPPLSTETHITL | 426 | Q9Y5H0 | |
| ETTTGFDPHRGTPLS | 256 | O60906 | |
| SAPTGITDHIVQGPD | 171 | Q9NX40 | |
| PAGTTDAAHPGRSVV | 501 | P05187 | |
| HGGSPQVTVTGPSRD | 666 | Q9HAP2 | |
| TPDVGLHQSLTSDPT | 186 | Q6PRD7 | |
| GGATSHLAPTDPADR | 706 | O75146 | |
| TPGSAGHDIITEQPR | 486 | P42858 | |
| SEAPSQARGHTPEGA | 511 | P0C671 | |
| TTTGTRAGGHPEEPL | 1826 | Q9Y6J0 | |
| SLERVGGHPTSPAAL | 306 | Q96B18 | |
| GSSLLPGEQPLHTVD | 231 | P09603 | |
| DGTLVVSGRDDPPTH | 41 | O75794 | |
| GRHGPESSPLNEVVS | 886 | Q9ULE3 | |
| IPATHNTGGSLPDLT | 236 | Q6UUV9 | |
| PRTTHLAGALSPGEA | 511 | Q9Y3X0 | |
| ASVDESHGISPPLQG | 816 | Q8IW35 | |
| QGSITRHDIDSPPAS | 236 | Q9P0K9 | |
| GSARLPSVGEESTHP | 171 | Q8WU20 | |
| ASPGSPHSGVQTSLE | 211 | Q6PGQ7 | |
| IGPSSPDLVVASEHS | 841 | Q8N3K9 | |
| LGSGLPPLVTSADEH | 1396 | Q8N3K9 | |
| RHSSTGDSADAGPPA | 871 | Q6ZU35 | |
| SILSPHPGEQSGGEE | 276 | Q5VZB9 | |
| HPGEQSGGEESPRSL | 281 | Q5VZB9 | |
| LTDSSRHSGVPEAPD | 711 | Q4KMG0 | |
| HEEGLLLAPSSVPSG | 411 | Q8TBE0 | |
| PENHADTIGSGRAIP | 246 | Q5VUJ5 | |
| PTHTPQDSLTGVGGD | 586 | Q9Y4J8 | |
| SDPNVLHSGEEGTPQ | 476 | Q8N6P7 | |
| EETSSNLPGKEHPGR | 536 | Q5T7N3 | |
| PVGPSTSTHSEDRHG | 26 | Q96G42 | |
| GSPTPTTHEIVTVGD | 2166 | Q03164 | |
| AGSQGTDSHTDLPPP | 91 | O14640 | |
| DVHIGSLSDPPNIAG | 91 | P14735 | |
| IGTVAAHDPDSSNSP | 396 | Q9ULB5 | |
| RPGPASTDSHEGSLQ | 121 | Q8NBF1 | |
| AREDSVSGPSHGPST | 3226 | Q9NYQ7 | |
| VSGPSHGPSTEQLDI | 3231 | Q9NYQ7 | |
| AGSQGTDSHTDLPPP | 91 | P54792 | |
| ARVVSHSSSPVGGPE | 206 | Q6ZVF9 | |
| PASVVDRSGALHPGD | 281 | Q9C0E4 | |
| NLSSTSHVPEVDPGS | 1476 | P49327 | |
| GEPGLSHSGSEQPEQ | 591 | P50895 | |
| TPHRDSLEPTEGSGA | 2226 | O95180 | |
| LSPGHGASAPSVSRE | 446 | Q6NUJ5 | |
| SSLEAHGPRSTLGPA | 201 | O43304 | |
| HGPRSTLGPALEAVS | 206 | O43304 | |
| ENAPGDEVPIGHSLT | 161 | Q8IZU8 | |
| SPEIEGDLQPATHGS | 151 | P51970 | |
| VEPHSPLRGGAQTEA | 2026 | Q8TDX9 | |
| EGPGSGESRLQHSPS | 681 | P80192 | |
| GSDSEGSLSPNPRLH | 211 | Q70SY1 | |
| PAIGTPLRDSSSSGH | 801 | Q15648 | |
| SGSESRVEPPHENGN | 411 | O75170 | |
| ISAEPGTVISPGSHV | 31 | Q6ISS4 | |
| IHTDSSPIVPSLGFG | 221 | P54317 | |
| PHSDAREGTAPSTTN | 421 | Q8WUT4 | |
| PSAASREAEHGPEVS | 16 | Q96DY7 | |
| PNGSRSHEPLSVDSV | 226 | Q9UKN5 | |
| PLRGENLTSEVGTHP | 591 | Q12889 | |
| TVTAHTDVGPGPESL | 686 | P23468 | |
| GASHESSGNPPLRVI | 316 | O94955 | |
| SRKGPASDTASPEGH | 506 | Q96RQ9 | |
| TDGRATEEHPSPFGI | 771 | A6ND36 | |
| HNGPSTPAKEGDTDR | 226 | O00167 | |
| VSSAGHGPRSSPAEL | 131 | Q9UQC2 | |
| AGVADLHVGATPSPL | 81 | Q96NZ1 | |
| LPPTSAHGNVAEGET | 26 | P02790 | |
| EGPPSEHSGISRNAI | 331 | P15151 | |
| TTPPVEVLHENESGG | 686 | O95197 | |
| STLRLPAHDTPGAGA | 86 | Q9H611 | |
| SPTSQPGGHESLVDR | 971 | P26640 | |
| SAIVSPHGDESPRGS | 491 | Q9Y6J9 | |
| SHSELQVPTPGRAGL | 491 | Q08AM6 | |
| VHPIPLESGGSSDVV | 606 | Q9NRF2 | |
| TPSQEGLPLEHVAGD | 376 | Q8IZ69 | |
| VEASSPGHGSPLSSL | 441 | Q8TEQ0 | |
| SVDLGSPSLASHPRG | 881 | Q7Z6B7 | |
| GTDRSVPHTNGLLSP | 456 | Q16650 | |
| GSSHITDSEQRELPP | 1236 | Q8WUY3 | |
| HAISGLLVPPDSSGS | 221 | Q9GZV8 | |
| SHLPGADLRPGETTG | 26 | O75069 | |
| DGNPKPIHGTTERSD | 161 | Q9NUQ6 | |
| RTGHSDIDESGPPLQ | 251 | Q14C87 | |
| DSGHLLTQSSPGEPT | 891 | Q6ZMZ3 | |
| LPASETAHGRISVGP | 426 | Q9P212 | |
| AVHSLEEPLPQTSSG | 221 | Q9UFD9 | |
| HGVTTASGETLPDPL | 846 | Q6ZWJ8 | |
| GHGPAETQTLGSLPD | 156 | Q8TDQ0 | |
| SEDTPLHTPSQGSLD | 1241 | Q9HAZ2 | |
| PTSQHGDLETPSSGD | 361 | O14594 | |
| RVEAHGEATATAPPS | 656 | O14594 | |
| THTDLASGAAGPVPA | 91 | Q96SF7 | |
| HSPSVLPSGGEESRS | 531 | Q8TE76 | |
| HTVEKPVPSSSGGDA | 816 | Q5JRX3 | |
| SDSHAGVRTGPESPA | 271 | Q8NDX1 | |
| AGDPEATSPGSHLLR | 606 | Q14524 | |
| HTPHTEDGGPSATER | 176 | P18827 | |
| GDTEVGSSLLRHPSP | 3506 | O75592 | |
| TPLHDGSRTPAQSGA | 806 | O00267 | |
| SAHEGRLSDPQLSGP | 1211 | Q9P2R6 | |
| ESQTLASGTAGHPEP | 16 | Q8TC41 | |
| GSLTLSAPSTHPVEG | 3916 | Q9P2P6 | |
| GGEASPSHIIRPLQS | 556 | Q9ULL5 | |
| SDPSIANHASVGPTL | 381 | Q68BL8 | |
| DGHRPTAEAPNTTAG | 311 | P40967 | |
| EHISPTLSVSGLGAP | 121 | Q15319 | |
| NTSGEESKHGLPPSE | 146 | O94903 | |
| GSPATEGELPTHEQV | 366 | Q8TCX5 | |
| PSVEHTGGANSAPRD | 341 | Q9NPE6 | |
| VHAIESLPGSGPLTA | 256 | Q9BXB5 | |
| GTEEHLPGLSSSPDQ | 31 | Q8WXE9 | |
| ASHVGGRPPQEETSA | 301 | Q76KP1 | |
| AGHSGSSPRDLLSPE | 1061 | Q13023 | |
| SAGHVAVSSPTPETG | 1321 | P42695 | |
| PAPNSVSITGSVDDH | 226 | Q14135 | |
| TPGTPGSHDLETALR | 486 | Q9UPV9 | |
| PINRGTEEGPGTSHT | 501 | Q5JTD0 | |
| TGPPTSAGEGHSRTE | 221 | Q63HN8 | |
| AGPVDAGVTQSPTHL | 16 | A0A597 | |
| AGSASSLHAPAGIPE | 141 | O60481 | |
| SEPREEGSAHLAVPG | 106 | Q9BZV1 | |
| DVSNHTLSLGPVPGA | 46 | Q9H9J4 | |
| PVLENSASAGDTSHP | 766 | Q9P217 | |
| DVTPENGPSGVHSRE | 216 | O15062 | |
| GHLGELAQSSVPPST | 241 | Q9Y330 | |
| GSAVDHPLSASLPTG | 1271 | O60673 | |
| PESPTGEGHNLSTDG | 276 | A8MU46 | |
| SHTPPVSGADSLLGS | 306 | P15923 | |
| AHEEESGGRSVPTTP | 2201 | P12270 | |
| PLAPSDSTGGSHSVR | 281 | Q71H61 | |
| HRSPATSAGPELAGL | 426 | A1L020 | |
| DHLTPRSPGTGTSSE | 1041 | Q9Y5Y9 | |
| SPSHPGALDLDGVSR | 291 | A1X283 | |
| SEVASGLQSATHPPG | 451 | Q8WWL2 | |
| DPSHPLLSNRGSSGD | 496 | Q8WWL2 | |
| SLHSLIETPANGTGP | 161 | P42226 | |
| EAGHHLPEPSSRETG | 241 | O76061 | |
| LPDVELSPSGGNHAE | 1276 | Q9BXM0 | |
| QTGETSLREQPHGGP | 111 | X6R8R1 | |
| GVTPPEELHTNSAEG | 1521 | Q8IWV7 | |
| SLHGLSQVSEDPPSV | 281 | Q71RS6 | |
| GASVPERPDEGIDSH | 506 | Q5T6S3 | |
| IHTDSVDGTPDPQRT | 216 | O94876 | |
| NAEPEPRSLSLGGHV | 11 | Q92599 | |
| THPIPLESGGSADIT | 496 | O14492 | |
| QDTPGSPDHRDASSI | 36 | O95359 | |
| RGNDHGTPIPTSDND | 36 | Q9Y6N7 | |
| EGPVDAGVTQSPTHL | 16 | A0A0A0MS05 | |
| EIEPQSSAHEPGGSL | 846 | Q9UGU0 | |
| HIGEGPSTISNSTIP | 531 | O60343 | |
| SLSGSTAIITDHPPE | 701 | Q63HK5 | |
| VHVGPSSPTDGQAAL | 291 | Q96JE7 | |
| IGDPHPTRSDISGAG | 716 | Q96JE7 | |
| VPETHLPGTGSSVAV | 801 | Q96JE7 | |
| EETPRASSPHQAGLG | 941 | Q96JE7 | |
| SSSHGPSDPTDRAEV | 476 | P54278 | |
| VSQESAPAGHTGISP | 91 | Q0VFX4 | |
| TPESESPQSHRAAGS | 41 | Q9C026 | |
| LSESESPQEAGRGHP | 911 | O43379 | |
| SHGLESVPVLPGSGE | 996 | Q641Q2 | |
| SLPTVHNEGPSSAEG | 206 | O75541 | |
| GLNVTTSHSPAAPGE | 401 | O43175 | |
| VPSPDGGSNHVTVSR | 251 | Q9NS98 | |
| SNHSVSPDPVLGSVA | 351 | Q2M1K9 | |
| GHEPGTVVDPSLDQA | 641 | P52746 | |
| SGLSSTDVPSGHPRA | 546 | Q5JPB2 | |
| DSNIPRSDHPKSTGE | 361 | Q8IWB9 | |
| LPPTAASQREGHTEG | 6 | Q8N988 | |
| PDSSSVSHGPVAGVT | 86 | Q9H4Z2 | |
| SEPTSGTEGPEHSVN | 1281 | P08575 | |
| NGSDHGDLRPPVTNT | 196 | Q7Z4V0 | |
| PDTSDHGGSTLLPPN | 41 | Q9NYI0 | |
| PASEGAQSLHPTESI | 956 | Q702N8 | |
| TVEHPGHPEVTTATG | 521 | P18583 | |
| ASAGLESHGRTPSPS | 391 | O75385 | |
| LTITGPSHPFLSGAE | 11 | O94842 | |
| EHPSEKQPSGAESGT | 661 | Q9NQA5 | |
| GPESSSSPGVHVRQT | 1091 | P49815 | |
| ESAAGPPTHEVLVTG | 306 | P29597 | |
| RAALSHSGSPGVVPE | 2911 | Q5THJ4 | |
| QGETREGSPHDKPTA | 551 | A6NN73 | |
| EATEGPSTHQGGPLA | 4036 | O14686 | |
| HSGPGSTETTLLPDN | 3336 | Q9UKN1 | |
| LPSVTDARSAGPSDH | 571 | O75113 | |
| EERSGPLHPGATSLG | 461 | Q92692 |